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SOMMARIO 
Diversi casi di leucemia linfoblastica acuta delle cellule T (T-ALL), una delle neoplasie 
associate a cellule T, nascono da timociti immaturi corrispondenti alle fasi iniziali di 
maturazione. Diversi sottotipi di T-ALL mostrano traslocazioni cromosomiche che coinvolgono 
gli elementi del promotore dei geni che codificano i recettori delle cellule T e fattori di 
trascrizione potenzialmente importanti nel processo di oncogenesi. Più recentemente, la 
deregolazione di microRNA, geni e fattori di trascrizione associati al normale processo di 
maturazione delle cellule T è stata indicata come ulteriore meccanismo coinvolto nella 
patogenesi delle cellule T. Per comprendere il ruolo dei microRNA nella regolazione dello 
sviluppo normale delle cellule T e nella patogenesi, sono state effettuate un'analisi 
bioinformatica su un dataset di timociti normali e una meta-analisi su una dataset di T-ALL. 
Nei timociti normali, è stata osservata una tendenza generale di up-regolazione dei microRNA 
nei timociti Singolo-Positivi (SP) rispetto ai Doppio-Positivi (DP), ad indicare che l'up-
regolazione di questi microRNA potrebbe causare la down-regolazione dei geni associati a un 
fenotipo immaturo. Diversi microRNA differenzialmente regolati tra SP e DP sono risultati 
essere coinvolti nel differenziamento cellulare, nella sopravvivenza cellulare e nell'apoptosi. 
La meta-analisi sul dataset di T-ALL ha identificato diversi fattori di trascrizione up-regolati in 
T-ALL rispetto ai timociti normali. Tra questi, abbiamo trovato alcuni fattori di trascrizione up-
regolati indipendentemente dal sottotipo di T-ALL che potrebbero interagire con fattori di 
trascrizione specifici di sotto-tipi per causare leucemogenesi delle cellule T. Tre microRNA 
sono down-regolati sia nel fenotipo immaturo DP e in T-ALL: hsa-miR-22, hsa-miR-26a e hsa-
miR-132. Questi microRNA potrebbero avere un ruolo nella regolazione di geni e fattori di 
trascrizione connessi con fenotipo immaturo di cellule T normali e nella leucemogenesi. È 
interessante notare che hsa-miR-22 è stato predetto avere come target ETS2, un fattore di 
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trascrizione up-regolato e coinvolto nella maturazione dei timociti. In sintesi, l'analisi 
bioinformatica suggerisce che microRNA, geni e fattori di trascrizione coinvolti nello sviluppo 
e nella fisiologia delle cellule T normali possano essere deregolati nel processo di 
trasformazione neoplastica e contribuire all'insorgenza di T-ALL. 
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ABSTRACT 
Several cases of T cell Acute lymphoblastic leukemia (T-ALL), one of the neoplasms 
associated with T cells, arises from immature thymocytes corresponding to initial stages of 
maturation. Different T-ALL subtypes have chromosomal translocations between promoter 
elements of the genes of T cell receptors and oncogenic transcription factors. More recently, 
the deregulation of microRNAs, genes and transcription factors associated with normal T cell 
development has been suggested as a further mechanism involved in T cell pathogenesis. In 
order to understand the role of microRNAs in the regulation of normal T cell development and 
pathogenesis, bioinformatics analysis was performed on a normal thymocytes dataset and a 
meta analysis was performed on a T-ALL dataset.   
In normal thymocytes, a general trend of up regulation of microRNAs was observed in Single 
Positive (SP) compared to Double Positive (DP), indicating that miR up-regulation could be 
important for down-regulating genes associated with an immature phenotype. Several 
differentially regulated microRNAs between SP and DP were found to be involved in cell 
differentiation, cell survival and apoptosis.   
Meta analysis on T-ALL dataset identified several up regulated transcription factors between 
T-ALL and normal thymocytes. Among these, we found few transcription factors up regulated 
irrespectively of T-ALL subtypes that may interact with sub type specific transcription factors 
to cause T cell leukemogenesis. Three microRNAs are down regulated both in immature 
phenotype DP and in T-ALL: hsa-miR-22, hsa-miR-26a and hsa-miR-132. These microRNAs 
may have possible roles in up regulation of genes and transcription factors associated with 
immature phenotype of normal T cell and in leukemogenesis. Interestingly, hsa-miR-22 was 
predicted to target ETS2, an up regulated transcription factor involved in thymocyte 
maturation. In summary, the bioinformatic analysis suggests that microRNAs, genes and 
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transcription factors involved in the regulation of normal T cell development and physiology 
may be deregulated in the process of neoplastic transformation and contribute to the onset of 
T-ALL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
7 
 
 INDEX  
SOMMARIO 3 
ABSTRACT 5 
1. INTRODUCTION 9 
1.1 T cell progenitors in the bone marrow 10 
Bone marrow T cell progenitors in experimental murine models 10 
Human T cell progenitors in Bone marrow 12 
1.2 T cell development in Thymus 13 
T cell development in Thymus of mice 13 
Genes and Transcription factors involved in Thymocyte Development in Mice 15 
Thymocyte Development in Human Thymus 18 
1.3 Identification of key oncogenes and Transcription factors in T- cell Acute lymphoblastic leukemia 19 
1.4 Selected Gene Expression profiles in T-ALL 22 
1.5 MicroRNAs in the Immune System 23 
1.6 MicroRNAs in T cell Development 27 
1.7 MicroRNAs in T cell acute lymphoblastic leukemia 31 
2. AIM OF THE STUDY 33 
3. METHODS 35 
PART 1 - BIOINFORMATICS ANALYSIS OF GENES AND MICRORNAS IN HUMAN T 
CELL DEVELOPMENT 35 
3.1 Data 35 
3.2 Computational analysis 35 
PART 2 – META ANALYSIS OF GENE AND MICRORNA EXPRESSION DATA IN T-ALL 36 
3.3 Genes Differentially Expressed between T-ALL and Normal Thymocytes 36 
3.4 TFs Differentially Expressed between T-ALL and Normal Thymocytes 36 
3.5 MicroRNAs Differentially Expressed between T-ALL and Normal Thymocytes 37 
MicroRNAs target prediction strategy 39 
 
 
8 
 
3.6 Integration of genes and microRNAs differentially expressed in T-ALL and Normal Thymocytes 41 
4. RESULTS 43 
PART 1 - BIOINFORMATICS ANALYSIS OF GENES AND MICRORNAS IN HUMAN T 
CELL DEVELOPMENT 43 
4.1 Differentially expressed microRNAs between Double positive and Single Positive thymocytes sub- 
populations 43 
4.2 Combined analysis of differentially expressed miRs and mRNAs in T cell development 45 
PART 2 - META ANALYSIS OF GENE AND MICRORNA EXPRESSION DATA IN T-ALL 48 
4.3 Genes Differerentially Expressed between T-ALL and Normal Thymocytes 48 
4.4 TFs Differentially Expressed between T-ALL and Normal Thymocytes 48 
4.5 Targets of MicroRNAs Differentially Expressed between T-ALL and Normal Thymocytes 50 
4.7 Additional Analysis on pathways 54 
5. DISCUSSION 57 
APPENDIX 1 61 
Selection of interesting transcription factors and their target genes from literature 61 
APPENDIX 2 65 
Gene Set Enrichment Analysis (GSEA) 65 
APPENDIX 3 69 
APPENDIX 4 77 
APPENDIX 5 81 
REFERENCES 83 
 
 
 
 
 
9 
 
1. INTRODUCTION 
Investigating the cancer genome is one of the most challenging tasks that oncologists are 
facing today. Different high throughput techniques like gene expression profiling, microRNA 
expression profiling, SNP genotyping, DNA methylation profiling, Copy Number variation 
profiling and deep sequencing technologies are being used to decode the hidden aspects of 
cancer development and progression. Since microRNAs have emerged as future diagnostic 
and prognostic tools in many different tumors, oncologists around the world frequently use 
microRNA and gene expression profiling to classify and study cancer. Role of microRNAs in 
regulating normal development of hematopoietic cells, epithelial cells, ectoderm cells are also 
reported in scientific literature. MicroRNAs are also known to regulate different transcription 
factors (TFs) and genes during neoplastic transformation of cells and during cancer 
progression and metastasis.  
Online databases like Gene Expression Omnibus (GEO) and Array Express report increasing 
number of gene expression and microRNA expression data. The availability of public datasets 
has attracted the attention of bioinformaticians and articles on meta analysis are increasingly 
published. In this thesis, bioinformatics approaches to study the role of microRNAs in the 
regulation of Normal T cell development and pathogenesis are presented.  
The work may be subdivided in two main parts:  
Part 1 - bioinformatics analysis of genes and microRNAs in human T cell development 
on a novel set of data;   
Part 2 - meta analysis of gene and microRNA expression data in T-ALL to reconstruct a 
TF-gene-microRNA network.  
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In the following sections, the main biological concepts and literature important for the 
development of the thesis are introduced.  
 
1.1 T cell progenitors in the bone marrow 
 
Bone marrow T cell progenitors in experimental murine models 
 
Different kinds of blood cells (granulocytes, monocytes, erythrocytes, megakaryocytes, B and 
T cells originate from hematopoietic stem cells (HSCs), which express high levels of cell 
surface markers like CD117(kit) and Sca-1. There are several models which have been 
proposed to elucidate the mechanism of hematopoesis. According to Adolfsson et.al  [1] 
specific population of these HSCs called short term haematopoetic stem cells develop into 
lymphoid primed multipotent progenitors (LMPP) (also known as ELP). These LMPPs have 
high levels of FLT3 and give rise to common lymphoid progenitor cells (CLPs) and 
Granulocyte-monocyte progenitors (GMPs). CLPs have high IL-7R alpha expression and are 
the true ancestors of B and T cells. These cells have very less potential to develop into 
myeloid lineage or megakaryocyte or erythroid lineage. 
Development of T cell lineage from CLP is mainly dependent on Notch Signaling. Pui et.al  
[2]has shown that mice which were reconstituted with bone marrow transduced with retrovirus 
encoding a constitutively active form of Notch1, showed an early block in B cell lymphopoesis. 
However, in a very interesting observation, Heinzel et.al [3] has showed that T cell 
progenitors (termed TMP - thymic multipotent progenitors) suppress anti- T lineage potential 
only after arriving in the thymic microenvironment. The journey from bone marrow to the 
thymus (where T cells mature further) is dependent on expression of a gene called CCR9, 
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which helps in thymic homing of T cell progenitors. Schwarz et.al [4] has shown that Flt3+ 
signaling and concomitant CCR9 expression by common lymphoid progenitors is necessary 
for thymic homing of pre thymic cells. HSCs injected into the blood of unirradiated mice were 
unable to settle within the thymus, whereas downstream CLP rapidly generated T lineage 
cells following intravenous transfer  [4].  
In another paper Scimone et.al  [5] has mentioned that P-selectin glycoprotein ligand 1 
(PSGL-1), α4β1/vascular cell adhesion molecule (VCAM) 1, lymphocyte function-associated 
antigen 1/intercellular adhesion molecule (ICAM) 1, and CCL25/CCR9 are key components of 
the unique thymus-specific recruitment pathway. Therefore, it is very clear that bone marrow 
progenitors of T cells must acquire the potential to migrate to thymus where they undergo 
further development to become functional T cells. After leaving the bone marrow the T cell 
progenitors circulate in the blood for a very short time. As a result there are few circulating T 
cell progenitors in the blood. However it is interesting to note that a specific type of T cell 
progenitors called CTPs (Circulating T cell progenitors) are a pre thymic population of cells 
(phenotype: c-kit low Thy1+) found in blood of adult mouse, which possess a strong T cell 
potential (very low B and NK cell potential) and are not affected by inhibition of Notch 
signaling  [6]. 
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Figure 1.1 Progenitor-Successor Relationships in T Cell Development within the bone marrow, 
Blood and Thymus [7]. 
 
Human T cell progenitors in Bone marrow  
 
It is very important to observe that the antigens expressed in murine haematopoesis are 
different from human haematopoesis although there are underlying similarities. In both the 
species mature functional cells develop from multipotent haematopoetic progenitors. Similar 
to murine models human bone marrow has CLPs, CMPs (common myeloid progenitors) and 
MEPs (megakaryocyte-erythrocyte progenitors).  
Pioneering work by Markus.G.Manz et.al.  [8] showed that lin-CD34+CD38+ human bone 
marrow cells which are IL-3R lo CD45RA- are common myeloid progenitors, where as IL-3R 
lo CD45RA+ cells are granulocyte monocyte progenitors. IL-3R-CD45RA- cells are 
megakaryocyte or erythrocyte progenitors. Another key paper on human haematopoesis by 
Anne Galy et.al  [9] states that CD34+, CD38+ CD45RA+ human bone marrow cells, which co 
express CD10 has the potential to develop into T cells, Natural killer cells or dendritic cells 
and lack erythroid myeloid and megakarocyte lineage potential. Journey from bone marrow to 
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thymus begins as early as eighth week of gestation in human. There are two types of 
migration- Vasculature dependent and Vasculature independent. Vasculature in dependent 
migration starts very early and is dependent on chemo tactic action of two molecules CCL21 
and CCL25 which are expressed in thymic primordium where as vasculature dependent 
migration starts at the later stages of embryogenesis and also postnataly.  
 
1.2 T cell development in Thymus  
 
T cell development in Thymus of mice 
 
T cell progenitors enter the thymus in the cortico-medullary junction and migrate towards the 
subcapsular zone. During this journey they are in close contact with the thymic stromal cells 
which express delta like ligands for the Notch receptors. Therefore the Notch Signaling is 
extremely important for T cell differentiation in the thymus. In this context it is important to 
note that three-dimensional architecture of the thymus is required to maintain delta-like 
expression necessary for inducing T cell development [10].T cell development within the 
thymus is an extremely complex phenomenon with several independent research groups 
reporting different models for interthymic T cell development. CD3- CD8-CD44+ CD25- Kit hi 
population are the earliest population of T cell progenitor in the thymus and are variously 
termed Double-Negative 1 (DN1), early thymic progenitors (ETPs), or DN1a cells. It is 
important here to mention that some of the early thymic progenitors (ETPs) retain myeloid 
lineage potential [11] and therefore it is suggested they do not originate from common 
lymphoid progenitors (CLPs) but from lymphoid primed progenitor cells (LMPPs). DN1 
develops to DN4 and the stages of development can be identified by the expression of 
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CD44+CD25+ (DN2), CD44-CD25+ (DN3) and CD44-CD25- (DN4). At DN2 stage multi 
lineage potential of thymocytes to develop into myeloid cells, NK cells or dendritic cells is 
completely lost. When the thymocytes arrive at the DN3 stage correct rearrangement of V(D)J 
genes occur, which allows the expression of TCR beta, TCR gamma and / or TCR delta 
genes. There are two types of thymocytes which are formed at this stage- one is alpha-beta 
receptor expressing thymocytes and another is gamma-delta receptor expressing thymocytes 
depending on the type of gene arrangement. Expression of TCR beta genes qualifies the 
thymocytes for "beta selection" which ultimately turns on CD4 and CD8 receptors on the cell 
surface. When the thymocytes, express both these receptors they have reached the double 
positive stage of thymocyte development.  
The alpha beta receptors expressing double positive thymocytes undergo through three key 
events 1) Positive selection 2) Negative Selection 3) Lineage differentiation i,e they either 
become CD4 positive or CD8 positive. Thymocytes at this stage interact with self peptide 
bound MHC molecules (I and II) and those thymocytes which do not interact die. This event is 
called positive selection and is an ideal mechanism to eliminate non reactive thymocytes. 
After positive selection occurs, thymocytes which have receptors with very high avidity for self 
peptide bound MHC are eliminated by TCR induced programmed cell death. This process is 
called negative selection and is an essential program to eliminate those thymocytes which 
undergo through positive selection and may have potential for autoimmune reaction. Another 
important event that occur here is the lineage choice between CD4 or CD8 single positive 
stage. It is very interesting to observe that the functional immune system is designed in such 
a manner that it matches with MHC specificity. Those thymocytes which interact with self 
peptide bound MHC-II molecules become CD4 T helper cells and those which interact with 
MHC-I become CD8 cytotoxic T cells. 
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Genes and Transcription factors involved in Thymocyte Development in Mice 
 
Transcription factors play stage specific roles in T cell development. The most important 
transcription factor which must be silenced at the DN2 stage for further T cell lineage 
progression is the ETS family transcription factor known as PU.1. Other transcription factors 
which has to be silenced before beta selection occurs are CEBP alpha, GATA2 and TAL1. All 
these transcription factors are responsible for pre thymic lineage plasticity. On the other hand 
there are some transcription factors which play essential role in T cell development, beta 
selection and survival of alpha-beta thymocytes. Wakabayashi et.al [12] stated that Bcl11b is 
essential for alpha-beta thymocyte survival.  
Similarly, HEBalt transcription factor and GLI2 (involved in hedgehog signaling are 
upregulated in early double negative stages and are important for T cell lineage 
differentiation. Between DN2 and DN3 transition several transcription factors like ETS1, 
ETS2, LEF1 are upregulated. DN3 also has a high level of transcription factor SPIB and 
Deltex1 (Notch target gene) but they are turned off after beta selection. SOX13 transcription 
factor decides between alpha beta and gamma-delta lineage thymocytes [13].  
It is very interesting to note that in response to Notch signaling there are a restrictive set of 
hematopoietic precursors which starts expressing T cell specific genes like GATA3 and TCF1 
transcription factors. There are four transcription factors which have been identified to 
"initiate" T cell lineage - these are Ikaros, PU.1, RUNX1 and CBF beta. On the other hand, a 
negative regulator of T cell lineage called LRF (leukaemia/lymphoma related factor, also 
known as Zbtb7a or Pokémon) counteract with Notch3 and Notch1 to keep the development 
of T cell lineage under control  [14].  
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Figure 1.2 Expression levels of differentiation and regulatory genes in early stages of T cell 
development  [15].  
 
Transcription factors and genes also play a major role in development of Double positive 
alpha beta thymocytes into single positive (CD4 or CD8). During positive selection T cells 
which cannot initiate TCR signaling die of apoptosis. Anti-apoptotic genes like Mcl1 (a Bcl-2 
family member) plays key role in T cell survival after its expression is upregulated by TCR 
signaling [16].  
As mentioned earlier,E2A and HEB transcription factors have key roles to keep the cell at the 
DP stage and prevent further differentiation until the beta selection gets over. Therefore, 
these are the main transcription factors which must be switched off by the cell if it wants to get 
differentiated into single positive from double positive stage [17]. It is again important to 
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mention in this context that four mature T cell genes II7r, foxo1, Ccr7 and klf2 are negatively 
regulated by these transcription factors (E2A and HEB). Apart from these, pioneering work by 
Patrik.S.Costello  [18] clearly indicated that during positive selection ERK pathway component 
Elk4 triggers Egr1 which increases the level of Id3, a key repressor of E2A-HEB transcription 
factors. In summary, it is very clear that several transcription factors are involved in DP to SP 
transition in mouse thymocytes. 
The two main transcription factors which are involved in deciding the final stage of T cell 
differentiation in the thymus into SPCD4 or SPCD8 are Runx3 and Thpok. Setoguchi et.al  
[19] showed that DP thymocytes differentiate into CD4 SP in presence of transcription factor 
Thpok. They also demonstrated that a Runx binding sequence in the locus of Thpok, silences 
its action and thus prevents CD4 lineage choice of the cell. Wang.L et.al  [20] showed that 
GATA3 transcription factor binds to Thpok and promotes its expression. Sakaguchi et.al  
[21]further demonstrated that a transcription factor named MAZR binds to the silencer of the 
gene encoding ThPok and therefore takes part in CD8 SP lineage choice of the thymocytes. 
After the final differentiation of the thymocytes inside the thymus, they egress the thymus to 
reach the peripheral lymphoid organs. In this process, the major role is played by zinc finger 
transcription factor klf2, which is upregulated by foxo1. According to Kerdiles et.al  [22] 
FOXO1 is an important transcription factor involved in T cell trafficking, homing and survival 
as it regulates IL7R,CCR7 and P-selectin molecule. 
Therefore, in summary multiple transcription factors and genes work in tandem to regulate 
thymocyte development inside mouse thymus. 
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Figure 1.3 Transcriptional circuitries in differentiating αβ T cells [15]: a. Pre-selection;  
b. Positive Selection. 
 
Thymocyte Development in Human Thymus 
For obvious reasons T cell development is mostly studied in mouse [23]. The only paper from 
which we get comprehensive information about human T cell development is from the paper 
of W.A Dik et.al  [23]. They isolated different subsets of human thymocytes based on surface 
markers and performed Gene expression profiling and PCR analysis in order to understand 
the human T cell receptor gene recombination and corresponding gene expression in great 
detail. In human, three distinct DN stages can be recognized- CD34+CD38−CD1a− stage that 
represents the most immature thymic subset and the consecutive CD34+CD38+CD1a− and 
CD34+CD38+CD1a+ stages. Human DN thymocytes mature via an immature single positive 
(ISP CD4+) and a DP stage into CD4+ or CD8+ SP T cells that express functional T cell 
receptors (TCR) and that exit the thymus. Based on hierarchical clustering analysis of 
different subsets of thymocytes and expression profiles of three key differentiation genes 
RAG1, RAG2 and PTCRA [23] Dik et.al  [23]suggested that human T cell development has 
many similarities with mouse T cell development in the thymus.  
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1.3 Identification of key oncogenes and Transcription factors in T- cell 
Acute lymphoblastic leukemia  
 
Approximately 15% and 25% of the newly diagnosed cases of acute lymphoblastic leukaemia 
(ALL) in children and adults, respectively, are T-cell ALL (T-ALL) and are historically linked 
with a poor prognosis [24]. 
Malignant thymocytes arise from normal counterparts during intrathymic T cell development 
and some of the oncogenes have been associated with differentiation arrest at particular 
stages of thymocyte development. The main cytogenetic features of the malignant 
thymocytes are chromosomal translocations between strong promoter elements of T cell 
receptor genes (TCRA,TCRG,TCRB) present in chromosome 7 and 14 and oncogenic 
transcription factors like TAL1, LYL1 and HOX11. It is also interesting to note that some of 
these transcription factors and oncogenes are present in very low level in T cells when 
compared to their malignant counterpart. Another interesting hallmark of T cell transformation 
are the phenomena of activating mutations in genes like NOTCH1 and FBW7. In this context, 
it is also important to state that the four proteins of NOTCH family - NOTCH1, NOTCH2, 
NOTCH3 and NOTCH4 have significant roles in T cell development as well as T- ALL 
induction [24]. Therefore, it is clear from the above discussion that a combined role of 
oncogenic transcription factors and activating mutations drive the development of T cell Acute 
lymphoblastic leukemia. Some of the transcription factor families involved in T-ALL are 
discussed below.   
Basic helix-loop-helix (bHLH) transcription factors  
One of the major bHLH transcription factor which is activated in 23% of T-ALL is TAL1. TAL1 
forms heterodimers with other bHLH proteins like HEB and E2A and acts as a transcriptional 
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repressor. Teresa Palomero  [25] has proposed a complex transcriptional network for TAL1 in 
which TAL1 not only acts a transcriptional repressor but also as a transcriptional activator 
which disrupts normal T cell homeostasis. Another bHLH protein which has structural motif 
similarity with TAL1 is LYL1. LYL1 is not expressed in normal thymocytes and is expected to 
play major roles in development of several blood tumours.  
 
HOX family transcription factors  
HOX family of transcription factors encoded by homeobox genes play significant role in T-ALL 
development. Translocations involving T cell receptor regulatory regions and HOX11 gene 
makes it highly activated in many cases of T cell lymphoblastic leukemia. HOX11 which is 
otherwise not expressed in normal thymocytes, is expressed aberrantly in T-ALL causing a 
developmental block at the DP stage of thymocyte differentiation. 
 
Notch Signaling and Notch1 Transcription factor  
Translocation involving NOTCH1 and T cell receptor locus regulatory regions is a rare 
phenomenon in T-ALL but an activating mutation of HD domain or PEST domain of NOTCH1 
protein makes it stable by masking it from the effect of ubiquitin ligase. As a result the notch 
receptor intracellular domain becomes activated and generates a signaling pathway, up 
regulating a plethora of target genes. The key target genes of this pathway are MYC and 
NFKB which further alter the normal T cell development and promote leukemogenesis. An 
important point to note in this regard is that 40% of genes identified by ChIP-chip as targets of 
NOTCH1 are involved in cell metabolism and protein biosynthesis. Two major pathways that 
are altered by NOTCH signaling are PI3-AKT signaling pathway and NFAT signaling pathway. 
Notch3, another member of the Notch family may be involved in T cell leukemogenesis. 
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Bellavia, D et.al [26] generated transgenic mice in which intracellular Notch3 was 
overexpressed specifically in T cells. These mice developed multi-organ infiltration of T 
lymphoblasts. Therefore, similar to NOTCH1, NOTCH3 may play role in T cell 
leukemogenesis. 
 
Figure 1.4 Rearrangements involving T cell Receptors Gene in T-ALL  [27].  
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1.4 Selected Gene Expression profiles in T-ALL 
 
 AUTHORS GENE EXPRESSION PROFILES 
Ferrando A.A.(2002) 
 
Using oligonucleotide microarrays, several gene expression signatures 
that were indicative of leukemic arrest at specific stages of normal 
thymocyte development were identified: LYL1+ signature (pro-T), HOX11+ 
(early cortical thymocyte), and TAL1+ (late cortical thymocyte) 
Yeoh E.J. (2002) Oligonucleotide microarrays were used to analyze the pattern of genes 
expressed in leukemic blasts from 360 pediatric ALL patients. Distinct 
expression profiles identified each of the prognostically important 
leukemia subtypes, including T-ALL, E2A-PBX1, BCR-ABL, TEL-AML1, 
MLLrearrangement 
Ferrando A.A.(2003) Interesting article about distinct subtype of T cell lineage leukemia "T-
ALL-MLL" which arises from T cells expressing gamma-delta T cell 
receptors(LYL1+)  
Chiaretti S. (2004) Identification of 19 genes which were differentially expressed between 
patients who had complete remission (CR) and patients who had 
subsequent relapse from T-ALL 
Kohlmann A.(2004) 
 
Gene expression patterns of the cohort of paediatric leukemia patients 
(including T-ALL) from Eng-Juh Yeoh et.al was collected and applied to a 
patient cohort of adult leukemia to see if that signature can differentiate in 
a similar manner also adult leukemias 
Martinez-Delgado B. 
(2004) 
Gene Expression Profiles to differentiate between Peripheral and 
Lymphoblastic Lymphomas 
Hoffmann K. (2004) Gene expression profiling t was done to find out the target genes of 
HOX11, the most important deregulated genes in T-ALL 
Palomero T. (2006) Gene Expression profiling data of primary human T-ALL subjects were 
used to identify direct targets of TAL1 and indentify a transcriptional 
network downstream of TAL1/SCL 
Clappier E.(2007) Identification of TCRB-MYB chromosomal translocation in very young T-
ALL patients which has a characteristic gene expression signature quite 
different from other T-ALL subtypes 
Coustan-Smith E. (2009) Gene expression profiling datasets of T-ALL was used and postulated 
that T-ALL originating from early T-cell precursors (ETPs), a recently 
defined subset of thymocytes that retain stem-cell-like features, would 
respond poorly to lymphoid-cell-directed therapy. 
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Sanda T. (2010) Gene set enrichment analysis (GSEA) and connectivity map analysis 
(CMAP), using gene expression data from both mouse and human T-ALL 
cells were used to identify changes in expression profiles during distinct 
phases of NOTCH1-mediated T-ALL development and to gain insights 
into small-molecule inhibitors that would synergize with or substitute for 
GSIs in the disease 
De Keersmaecker K. 
(2010) 
A gene expression profiling was done to identify gene signature 
corresponding to TLX1-transgenic mouse and compared it to human T-
ALL samples. 
Cleaver A. (2010) Gene expression profiling from T-ALL patients were used to identify a five 
gene classifier which can accurately predict clinical outcome in T-ALL 
patients. 
Messina M. (2010) Gene expression profiling was done to identify distinct set of genes which 
encode protein tyrosine kinase and which gets differentially regulated in 
T-ALL subsets. 
Haferlach T. (2010)  
 
Massive study to understand the clinical utility of microarrays based gene 
expression profiling in the diagnosis and subclassification of leukemia. 
 
Table 1.1 Selected gene expression profiles in T-ALL from literature. 
 
1.5 MicroRNAs in the Immune System 
 
1) A General overview of MicroRNA Biology 
 
MicroRNAs are small nucleotide molecules (approximately 22- 23) which are non coding in 
nature and which bind to mRNA molecules and cause degradation or repress their translation  
[28]. First microRNA, lin-4 was discovered in C.Elegans and was shown to be involved in 
larval developmental by reducing the level of LIN-14 protein  [29]. Approximately 30% of all 
protein coding genes are predicted to be under the control of microRNAs. Therefore, genes 
are not only regulated during transcription by multiple transcription factors and co factors but 
also by microRNAs, which binds to these genes post transcriptionally and repress the 
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formation of the protein. MicroRNA precursors are transcribed as several nucleotides length 
molecules and are processed inside the nucleus by DROSHA-DGCR8 microprocessor 
complex to form pre-miRNAs (approximately 70 nucleotides of hairpin structure) [30].These 
pre-miRNAs are exported outside the nucleus by a Ran-GTP complex called Exportin-5  [31]. 
Inside the cytoplasm, these pre-miRNAs are further processed by DICER to form 
approximately 22-23 nucleotide length double stranded RNA molecules.  
These double stranded RNA molecules are recognized by RISC complex and one of the 
strand (guiding strand) binds to the mRNA causing its degradation or translational repression.  
The other strand called passenger strand gets degraded. In this context it is interesting to 
discuss two papers - one by Biasiolo et.al  [32] and another by Ro.S et.al  [33] which describe 
that the passenger strand is not always degraded (also known as star microRNA) but are 
concurrently or alternatively expressed with the other strand depending on the cell type. 
 
2) MicroRNAs in innate immune response - Regulation of key genes and 
transcription factors 
 
 
a) MicroRNAs in myeloid cell development 
MicroRNAs are involved in both innate and adaptive immune system function. But since 
granulocytes, macrophages, dendritic cells and natural killer cells (components of innate 
immune response) form the first line of defence against the foreign antigens, role of 
microRNAs in regulating this branch of immune system is discussed first. From the 
developmental point of view, three microRNAs namely microRNA106a, microRNA17-5p and 
microRNA20a are involved in suppressing the transcription factor RUNX1, and thus 
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preventing differentiation of GMP into monocytes. During differentiation of monocytes into 
macrophages, above mentioned microRNAs are down regulated  [34]. 
 Another important master regulator transcription factor PU.1 upregulates microRNA424 
which in turn down regulates another transcription factor NFIA and promotes monocytes 
differentiation  [35]. Influence of microRNAs on granulocyte development from GMP is 
regulated by transcription factor Gfi1 which regulates microRNA21 and microRNA196b to 
control granulopoiesis  [36]. Another very interesting paper on neutrophil differentiation and 
activation was reported by JB. Johnidis  [37].  
He showed that microRNA223 negatively regulates granulocyte proliferation and activation by 
targeting transcription factor Mef2c. It is also very important to note that microRNA223 can be 
induced by two transcription factors C/EBP-alpha and PU.1 and therefore these transcription 
factors play significant role in granulocyte biology.  
 
b) MicroRNAs in inflammatory pathways  
Five most important microRNAs involved in inflammatory responses of the macrophages are 
microRNA146, microRNA155, microRNA147, microRNA21, microRNA9. MicroRNA-146a is 
involved in negatively regulating NFKB mediated Toll like receptor (TLR) pathway, in 
response to various pro-inflammatory signals. It binds to the 3 prime UTR and down regulates 
two molecules IRAK1/2 or TRAF6 which are key adaptor molecules involved in TLR pathway. 
Therefore, it fine tunes the innate immune response by providing a negative feedback in 
response to inflammatory signals. This finding was first reported by Konstantin. D. Taganov et 
al  [38], who performed a microarray profiling of 200 microRNAs in human monocytes and 
identified hsa-miR-155 and hsa-miR-132 other than hsa-miR-146a to be involved in innate 
immune response and pro-inflammatory pathways. Recently, hsa-miR-146a has been 
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projected as a major therapeutic and prognostic target in rheumatoid arthritis and 
osteoarthritis. MicroRNA-155, another important molecule involved in innate immune 
response as mentioned above is an effective negative modulator of TLR pathway in response 
to microbial stimuli. This function was reported by Maurizio Ceppi et.al [39] who also 
performed a microRNA profiling of human monocyte derived dendritic cells stimulated by 
lipopolysaccaride. MicroRNA21 role in repressing the gene PDCD4 was discovered by 
F.J.Sheedy  [40]. By repressing PDCD4, microRNA plays an anti-inflammatory role by 
negatively regulating NFKB and IL-10 production after lipopolysaccaride stimulation. Flavia 
Bazzoni et.al  [41] reported that MicroRNA9 targets NFKB1 transcription factor in response to 
lipopolysaccaride stimulated TLR4 signal and like microRNA-146 forms a negative feedback 
loop in response to pro inflammatory signal. Therefore, in summary different microRNAs play 
crucial role in fine tuning the innate immune system in response to microbial infections.  
 
3) MicroRNAs in adaptive immune response - B cell related microRNAs and 
transcription factor. 
 
Though adaptive immunity consists of both B and T cells response, in this section the role of 
microRNAs in B cell development is briefly discussed based on few published papers. A 
much detailed discussion of microRNAs in T cell development will be done in the subsequent 
sections of the introduction. 
Similar to T cells, B cells also undergo through several steps of maturation from 
haematopoetic stem cells to mature B cells. During this process rearrangement / 
recombination of immunoglobulin genes (Variable Diverse Joining) occur in the bone marrow. 
(instead in T cells, T cell receptor genes Variable Diverse Joining occur in thymus). During 
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this process of maturation, microRNA150 targets c-myb transcription factor  [42], a key 
transcription factor involved in B cell development. Again similar to T cells, B cells react with 
antigens in the peripheral lymph nodes where they undergo germinal centre reaction and form 
either plasma cell (antibody producers) or memory B cells. Basso.K et.al  [43] reported 
distinct microRNA signatures corresponding to specific stages of B cell development in the 
periphery (naive, centroblast, memory) by performing microRNA profiling of these cell types. 
Another microRNA which has a reported role in B cell germinal centre reaction is 
microRNA155. It is also reported to play key role in class switching mechanism of antibody 
subtypes in peripheral plasma B cell [44]. Therefore in summary, microRNAs also play 
significant role in the maturation and differentiation of B cells in bone marrow and peripheral 
lymphoid organs.  
1.6 MicroRNAs in T cell Development 
 
Involvement of microRNAs in T cell development inside the thymus and also in T cell 
activation and differentiation in the periphery is studied in great detail by immunologists all 
over the world. Different subpopulations of T cells play diverse role in adaptive immune 
response against various diseases. As for example, different T cell populations not only 
infiltrate growing tumors in the body but also play key roles in combating against many deadly 
virus, which specifically infect certain sub population of T cells.  
Therefore, studying the role of microRNAs in normal T cell physiology and also in T cell 
pathologies may provide the researchers with interesting clues regarding the understanding of 
various diseases and neoplasms. In the following paragraphs, brief descriptions of different 
microRNA profiling reports on Normal T cell subpopulations are described. 
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1) Microarray profiling of the murine haematopoetic system by Silvia 
Monticelli et.al, [45]  
 
It is one of the earliest works on microRNA profiling of the haematopoetic system. They 
performed microRNA profiling with 181 mature miRNAs. Even though only selected 
hematopoietic cell lineages were analyzed, each differentiation step was characterized by 
changes in miRNA expression, with some miRNAs showing increased and some showing 
decreased expression. MiR-150 expression is of particular interest: this miRNA is up-
regulated during the developmental stages of B and T cell maturation, but down-regulated 
again during the further differentiation of naïve T cells into effector Th1 and Th2 cells.  
 
2) Microarray profiling of murine Naive, Effector and Memory CD8 T cells by 
Haoquan Wu et.al,  [46]  
 
In this paper authors have used three different technologies to profile microRNAs in different 
subpopulations of CD8 T cells- miRNA Microarray, Real Time PCR and small RNA cloning. 
They reported that 7 miRNAs (miR-16, miR-21, miR-142-3p, miR-142-5p, miR-150, miR-15b 
and let-are highly expressed in CD8 T cells as compared to other microRNAs.)  
 
3) Differential expression of microRNAs in human hematopoietic cell lineages by 
Michaela Merkerova et al 
This interesting paper [47] describes the microRNAs which are upregulated specific to a 
haematological subpopulation. (isolated from peripheral blood of 10 healthy individuals) 
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4) A mammalian microRNA expression atlas based on small RNA library 
sequencing [48] 
 
In this interesting paper considered as one of the milestone papers in microRNA research 
authors sequenced small RNAs in haematopoetic sub populations.  
 
5) Distinct microRNA signatures in human lymphocyte subsets and enforcement of 
the naive state in CD4+ T cells by the microRNA miR-125b  [49] 
In this landmark paper authors have isolated 17 different subpopulations of human peripheral 
CD4 T cells and performed microRNA profiling. From this expression profiling they identified 
microRNA-125b as the most differentially regulated microRNA between naive and effector 
memory CD4 T cells. In order to identify the targets of hsa-miR-125b, they combined gene 
expression analysis with the predicted targets of hsa-miR-125b. They have termed this 
method as ACEPT (anti-correlated expressed predicted targets). 72 ACEPT mRNAs for miR-
125b were significantly enriched for the biological function of cell-mediated immune response 
and the canonical pathway of helper T cell differentiation.Furthermore, ACEPT mRNAs for 
miR-125b generated a network of 133 gene products that included several molecules 
involved in T cell differentiation, such as cytokines, cytokine receptors and transcription 
regulators (Rossi,RL, Nature Immunology, 2011). From this list of ACEPT genes they chose 
14 genes involved in peripheral CD4 T cell differentiation. Out of these 14 genes they 
reported 4 genes IFNG, IL2RB, IL10RA and PRDM1 to be direct targets of hsa-miR-125b.  
6) MicroRNAs in T cell development and differentiation- Regulation of key genes 
and transcription factors 
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Before discussing the role of microRNAs in T cell development and differentiation, it will be 
interesting to mention the paper by Sandberg.R et.al  [50] which tells that prolifirating T cells 
have transcripts whose UTRs are shorter than resting T cells and as a result have much more 
fewer microRNA targets than resting T cells. However, there are some interesting 
experimentally validated targets in T cells. Li Q,J. et.al  [51] identified that microRNA181a 
represses signaling molecules of MAP kinase pathways namely,  
DUSP5 and DUSP6, SHP-2 and PTPN22 and inhibition of these microRNA can result in 
marked decrease of positive and negative selection in mature T cells of mouse. In another 
paper by Joel.R.Nielson et.al [52], it was shown that several genes, CD69, Bcl-
2,Tox,transcription factor Runx1, and transcription factor Egr1 are targeted by microRNA181. 
Interesting paper by Changchun Xiao et.al  [53] showed that microRNA cluster 17-92 is highly 
expressed in immature T cells and its expression gradually decreases in mature T cells. They 
also demonstrated that this cluster regulates Pten and Bim, two genes involved in apoptosis 
and cell proliferation pathways. In another landmark paper, Curtale, G et.al  [54] 
demonstrated that hsa-miR-146a is not only involved in innate immune response but also is 
an active player in adaptive immune response. They showed that microRNA-146a is highly 
expressed in activated human T cells and has an antiapoptotic function. It also targets FADD, 
a gene involved in apoptotic pathway. Finally it is time to mention about a paper by Li-Fan-Lu 
et.al  [55] where he found that microRNA155 induced by transcription factor FOXP3 plays 
crucial role in a specific sub- population of T cells called Tregs in which it suprreses SOCS1 
and impairs the function of transcription factor STAT5. In conclusion, it can be said that 
microRNAs play significant role in different subpopulation of T cells by regulating several 
genes and transcription factors involved in multiple cellular pathways. 
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1.7 MicroRNAs in T cell acute lymphoblastic leukemia 
 
After writing about the role of microRNAs in normal T cells, it is necessary to understand the 
roles of microRNAs in one of the T cell related neoplams, T cell acute lymphoblastic leukemia 
(T-ALL). For this purpose a thorough literature search was performed to collect the papers 
which deal with microRNAs associated with T-ALL. 
The first microRNA profiling on acute lymphoblastic leukemia (ALL, in which T-ALL samples 
were also present) was published by ML den Boer group in the year 2009 [56]. 
The role of transcription factors TLX1, TLX3, NKX2-5 (associated with translocation: T cell 
receptor promoter elements) in increasing the levels of microRNA17-92 cluster (miR-17-3p, 
miR-17-5p, miR-18a, miR-19a, miR-20a, miR-19b and miR-92) was reported by Stefan Nagel 
et.al [57]. Kaddar.T et.al  [58] published a paper in which they reported the prognostic value of 
microRNA16 in T cell acute lymphoblastic leukemia. Valerio Fulci et.al [59] performed 
microRNA profiling on both B and T lineage lymphoblastic leukemia and identified three 
microRNAs miR-148, miR-151, and miR-424 as discriminative of T-lineage versus B-lineage 
ALL. Pioneering works on microRNA research of T-ALL was performed by Konstantinos J 
Mavrakis et.al  [60]. They identified microRNA 17-92 cluster (microRNA19) targets tumor 
suppressors Bcl2l11, Prkaa1, Pten and PP2A and concluded that microRNA 19 is highly 
expressed in T-ALL and is oncogenic in nature. In the other paper, they identified five 
microRNAs namely microRNA19b, microRNA20a, microRNA26a, microRNA92, 
microRNA223 as highly expressed microRNAs in T-ALL and discovered that they target 
(overlapping targets) tumor suppressor genes like PTEN, BIM, PHF6, NF1 and FBXW7 to 
form a cooperative network. Before writing about few other recent papers and microRNA 
profiling experiments, it is necessary to mention that other than microRNA 17-92 cluster 
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another microRNA which is slowly gaining importance in T-ALL microRNA research is 
microRNA 223. Although, microRNA223 has been marked as a myeloid specific microRNA 
and has been studied widely, it is also highly expressed in T-ALL cases [60].  
Further, in a very exciting paper, Sabina Chiaretti et.al [61] has studied 69 untreated T-ALL 
cases by Real-Time Quantitative PCR and reported high expression of microRNA-223 and 
myeloid specific genes like CEBPA, MPO, GRN and IL8.  
In another very recent paper, Samuel Gusskott et.al [62] reported that microRNA-223 is highly 
upregulated (identified by microRNA profiling) in T-ALL cells (Jurkat and P12 Ichikawa cell 
line) while they were treated with GSI to block Notch Signaling. They also stated that Notch 
pathway regulated microRNA223 may directly repress target gene IGF1R, one of the main 
genes in IGF1 signaling pathway (which is also regulated by Notch pathway). 
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2. AIM OF THE STUDY 
 
The main aim of the study is to investigate the role of microRNAs in the regulation of normal T 
cell development and pathogenesis. In order to achieve this aim, a bioinformatics analysis 
was performed on normal thymocytes dataset and a meta analysis was performed on T cell 
acute lymphoblastic leukemia dataset. 
AIM1  
Analyze the microRNA and mRNA expression profiles corresponding to Double Positive and 
Single Positive stages of thymocyte development and identify microRNAs regulating 
important genes during thymocyte development.  
AIM2  
Compare the gene expression data of normal thymocytes and T-ALL and combine this data 
with microRNAs differentially expressed to construct a network of microRNAs targeting 
differentially regulated genes and transcription factors.  
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3. METHODS 
 
PART 1 - Bioinformatics analysis of genes and microRNAs in 
human T cell development  
3.1 Data 
MicroRNA expression profiles in normal human thymus tissue, purified DP, SP CD4+, and SP 
CD8+ human thymocytes were investigated with the Human miRNA Microarray kit Version 2.0 
(Agilent Technologies), which allows detection of 723 known human and 76 human viral 
miRNAs (miRBase Version 10.1.). Six biologic replicates for each T-cell population were 
hybridized on the arrays. Total RNA was labeled with the miRNA Complete Labeling and Hyb 
Kit (Agilent Technologies); fluorescent signals were extracted and analyzed with Feature 
Extraction Software (Version 9.5.3.1; Agilent Technologies).  
Gene expression profiles of DP and SP CD4+ human thymocytes were obtained by 
hybridization on Human genome U-133 PLUS microarrays (Affymetrix). Three to 6 biologic 
replicates for each sample were hybridized on the arrays. Gene expression data were 
extracted by GeneChip software Affymetrix Microarray Suite 5.0 [MAS 5.0]. 
3.2 Computational analysis 
 
Computational analysis was performed by the candidate in collaboration with Alberto 
Corradin. Gene-Microarrays were normalized by applying the Robust Multichip Average 
(RMA) procedure, whereas no normalization method was applied in case of microRNA 
microarrays. Differentially expressed features were identified by Significance Analysis of 
Microarrays (SAM) [63], as implemented in the BRB Array Tools <http://linus.nci.nih.gov/BRB-
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ArrayTools.html>, ver 3.6, and adopting a False Discovery Rate (FDR) of 0.001. Hierarchical 
clustering of samples was performed using the same software package. Heat maps were 
obtained with Genesis software package. Functional Annotation Clustering was performed 
using DAVID software <www.david.abcc.ncifcrf.gov>  [64]. 
 
 
 
 
PART 2 – Meta analysis of gene and microRNA expression data 
in T-ALL 
 
3.3 Genes Differentially Expressed between T-ALL and Normal 
Thymocytes 
 
A data set containing 174 T-ALL samples [65] was collected from Gene Expression Ominibus 
<http://www.ncbi.nlm.nih.gov/geo/> (GSE 13204) and compared to 6 normal thymocytes 
samples, analysed in the first part of the thesis. Data were normalized using Robust Multichip 
Average (RMA) method and genes differentially regulated between normal thymocytes and T-
ALL were evaluated using the limma package [66] in collaboration with Angela Grassi.  
 
3.4 TFs Differentially Expressed between T-ALL and Normal Thymocytes 
Among the differentially expressed genes, transcription factors highly up regulated (> 2.5 Fold 
Change) were selected using the recently developed HTRIdb database (2012). Next a 
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software called CONFAC [67] was used to look for the binding sites of these transcription 
factors in strongly down and up regulated genes (Fold change < -5 or > 5). Conserved 
transcription factor binding site (CONFAC) software enables the high-throughput identification 
of conserved transcription factor binding sites (TFBSs) in the regulatory regions of hundreds 
of genes at a time. The output of the CONFAC software is a table in which each column 
represents a given gene, and each row represents a transcription factor in the TRANSFAC 
database [67].   
 
3.5 MicroRNAs Differentially Expressed between T-ALL and Normal 
Thymocytes 
MicroRNAs have emerged as key players in the regulation of immune responses, both innate 
and adaptive. Since microRNAs are known to regulate genes, differentially expressed 
microRNAs in T-ALL vs normal thymocytes were collected from literature in order to 
hypothesize relationships between genes, transcription factors and microRNAs, all 
differentially regulated between T-ALL and thymocytes. MicroRNA data were obtained from 
[68] and are reported in Table 3.1. 
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MicroRNA FC STATUS 
hsa-miR-107 5.66 Upregulated 
hsa-miR-126 5.89 Upregulated 
hsa-miR-145 14.73 Upregulated 
hsa-miR-190 2.64 Upregulated 
hsa-miR-223 8.71 Upregulated 
hsa-miR-27a 2.37 Upregulated 
hsa-miR-320a 2.05 Upregulated 
hsa-miR-132 0.008 Downregulated 
hsa-miR-146a 0.19 Downregulated 
hsa-miR-151-3p 0.07 Downregulated 
hsa-miR-193b 0.07 Downregulated 
hsa-miR-205 0.001 Downregulated 
hsa-miR-206 0.005 Downregulated 
hsa-miR-22 0.31 Downregulated 
hsa-miR-26a 0.45 Downregulated 
hsa-miR-296-5p 0.06 Downregulated 
hsa-miR-433 0.002 Downregulated 
hsa-miR-549 0.07 Downregulated 
hsa-miR-564 0.01 Downregulated 
hsa-miR-566 0.03 Downregulated 
hsa-miR-575 0.01 Downregulated 
hsa-miR-601 0.14 Downregulated 
hsa-miR-639 0.02 Downregulated 
hsa-miR-646 0.07 Downregulated 
hsa-miR-650 0.13 Downregulated 
hsa-miR-708 0.03 Downregulated 
 
Table 3.1 Differentially Regulated microRNAs between T-ALL and Normal thymocytes.  
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MicroRNAs target prediction strategy 
 
Predictions of microRNA targets in animals is a challenging task because of incomplete 
complementarily between microRNA and its target sites and lack of sufficient scientific 
knowledge about the process controlling the microRNA-mRNA interaction. Several microRNA 
target prediction algorithms have been designed to predict microRNA targets in animals. 
In the paper of Baek et.al  [69] it is mentioned that TargetScan and Pictar performed better 
than other considered softwares in identifying true targets for hsa-miR-223 (insilico targets for 
hsa-miR-223 were compared with down regulated proteins, identified by mass- spectrometric 
method). Also in 2009’s paper of Papodopulus  [70] it was indicated that both Pictar and 
TargetScan performed very well in terms of precision and sensitivity as compared to other 
softwares, when their predictions were compared with the pSILAC data of Selbach et al  [71]. 
In another paper Shirdel et.al  [72] have shown Pictar and TargetScan to have high Precision 
and PITA to have a high Recall, when compared to publicly available high-throughput 
microarray data. According to T.M. Witkos et.al,  [73] the most suitable approach for miRNA 
target prediction seems to be dependent on the nature of the planned experiments. Also in 
the paper "MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining 
biological functions of microRNA expression" [74] authors have used three software (PicTar, 
TargetScan, PITA) for their analysis. Considering all these above mentioned factors, it was 
decided to use an union of TargetScan(conserved) and PicTar(4) and intersect them with 
PITA ALL predictions (targets were downloaded from mirDIP database). Finally the results 
from the above three databases were merged with miRTarBase, a database of experimentally 
validated targets.  
This was done to achieve 2 main purpose: 
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1) A balance was achieved between two main target recognition properties of softwares - a) 
Evolutionary Conservation and b) Target Site accesibility and also between two main 
measures of relevance a) High Recall (PITA ALL Targets) b) High Precision (TargetScan and 
PicTar). 
2) A mutual intersection of all softwares used in mirDIP, showed that "PITA All Targets" 
shares about 85% of targets with both TargetScan (conserved) and PicTar(4), Figure 3.1, and 
so by intersecting the predicted targets of TargetScan union PicTar with PITA, a good number 
of reliable putative targets were obtained. 
 
Figure 3.1 Mutual Intersection of all softwares used in mirDIP. Normalized values are obtained by 
dividing the number of targets predicted by each software in the column by the number of targets 
predicted by the software in a row.  
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3.6 Integration of genes and microRNAs differentially expressed in T-ALL 
and Normal Thymocytes 
 
The genes found to be targets of differentially regulated microRNAs were intersected with 
differentially regulated genes between T-ALL and Normal thymocytes in order to reconstruct a 
microRNA gene network. A further step was performed to reduce the number of genes in the 
network. Genes which were differentially regulated (>5 or < -5 fold) as well as putative targets 
of at least one of the 9 transcription factors were intersected with differentially regulated 
microRNA targets. A comprehensive gene -microRNA network was created with these 
microRNA- gene pairs along with the transcription factors by using "Advanced Network Merge 
Plugin in Cytoscape".  
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4. RESULTS 
 
PART 1 - Bioinformatics analysis of genes and microRNAs in 
human T cell development  
4.1 Differentially expressed microRNAs between Double positive and 
Single Positive thymocytes sub- populations 
 
Hierarchical clustering indicated that each thymic population was characterized by a distinct 
miR expression pattern which reflected the developmental relationships across maturation 
stages in T precursors. In particular, DP thymocytes showed a miR profile quite distinct from 
those of CD4+ and CD8+ SP cells; on the other hand, expression profiles of the two SP 
populations showed important similarities (Figure 4.1).Significance Analysis of Microarray 
(SAM) revealed that 70 miRs were differentially regulated in SP compared to DP thymocytes 
(60 up-regulated and 10 down-regulated) (Figure 4.2). Interestingly, a general up-regulation 
was observed in the maturation of thymocytes from the DP to the SP stage.  
 
 
Figure 4.1 Hierarchial Clustering of different thymocyte sub populations. 6 samples for each 
thymic subpopulation have been used for analysis. 
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Figure 4.2 Differentially Expressed microRNAs between Double Positive and Single Positive 
thymocyte sub populations. Up regulated microRNAs are colored red and down regulated 
microRNAs are colored green. Notice that hsa-miR-150 is one of the most differentially regulated 
microRNAs. 
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4.2 Combined analysis of differentially expressed miRs and mRNAs in T 
cell development 
miR-mRNA interactions may lead to degradation of the mRNA, integration of gene expression 
data with miR expression profiles can facilitate identification of genuine mRNA targets from 
the long list of potential targets provided by prediction algorithms. To exploit this approach, 
the mRNA expression profiles of T cells during their maturation from DP to SP CD4+ cells 
were analysed using the HG-U133 Plus 2.0 platform (Affimetrix): 702 genes were identified as 
up-regulated in SP compared with DP, whereas 351 were down-regulated. The Functional 
Annotation Clustering tool implemented in the DAVID website <www.david.abcc.ncifcrf.gov> 
confirmed that a high number of these differentially expressed genes were involved in T-cell 
activation and differentiation (Table 4.1).  
 miRBase [75] and TargetScan [76] software packages were used to predict targets of miRs 
that were differentially expressed in SP CD4+ versus DP cells. Comparison of the list of 
targets identified by both algorithms with the subset of genes observed to be differentially 
expressed during T-cell maturation yielded a group of candidate targets whose expression 
was inversely correlated to that of related miRs. Functional Annotation Clustering performed 
on this restricted subset of targets revealed an enrichment in genes involved in regulation of 
the cell cycle and mitosis (Table 4.2). Several of these targets were of potential interest 
because of their known role in the control of T-cell survival, proliferation, and differentiation as 
well as neoplastic transformation, including NOTCH3, BCL2L1, CDKN2D, and NFKB1. 
NOTCH3, in particular, was experimentally validated as target of hsa-miR-150 by Margherita 
Ghisi  [77]. 
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Table 4.1 Functional Annotation Clustering of the genes differentially expressed between DP 
and SP stages of thymocyte differentiation. 
 
 
47 
 
 
Table 4.2 Functional Annotation Clustering of the candidate microRNA target genes 
differentially expressed between DP and SP stages of thymocyte differentiation. 
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PART 2 - Meta analysis of gene and microRNA expression data in 
T-ALL 
4.3 Genes Differerentially Expressed between T-ALL and Normal 
Thymocytes 
 
Differential expression analysis identified about 9000 probes differentially regulated between 
T-ALL and normal thymocytes corresponding to 6445 genes (at FDR < 0.01). Only genes with 
all the probes regulated in the same direction (up regulation or down regulation) were 
considered, reducing the number of genes to 6161 (3125 upregulated and 3036 down 
regulated).  
 
4.4 TFs Differentially Expressed between T-ALL and Normal Thymocytes 
 
Out of 6161 differentially regulated genes, 32 transcription factors, obtained from HTRIdb 
database, are up regulated above 2.5 fold in T-ALL when compared to normal thymocytes 
(Table 4.3A). Among these transcription factors TAL1 deserve special mention because it has 
been implicated in T cell acute lymphoblastic leukemia. GATA2 is also an extremely important 
transcription factor involved in thymocyte development. GATA2, CEBPA, TAL1 which are 
expressed in early stages of T cell development like ETP and DN1 needs to be switched off 
before beta selection occurs. ETS transcription factors are specifically up regulated between 
DN2 and DN3 stages indicating their precise role in thymocyte development. RUNX1 
described as a key gene in T-ALL, is also involved in initiating T cell lineage development. 
Therefore, several transcription factors which are involved in thymocyte development may be 
involved in T cell pathogenesis.  
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Transcription Factors 
NFIL3 
NFE2 
MAFF 
ATF3 
ERG 
JUN 
RORA 
CEBPD 
TAL1 
ZEB2 
E2F3 
NFIC 
GFI1B 
GATA2 
FOSL2 
REST 
CEBPB 
RUNX1 
NFAT5 
TCF7L2 
LRRFIP1 
ETS2 
DDIT3 
RARA 
ETS1 
CEBPA 
SPI1 
MAX 
PAX5 
NFATC2 
RXRA 
STAT3 
 
Table 4.3A. Transcription factors differentially regulated between T-ALL and normal 
thymocytes. 
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Tanscription Factors  Number of Transcription Factor Binding Sites 
NFE2 444 
ATF3 286 
TAL1 741 
GATA2 1104 
ETS2 1236 
ETS1 1982 
STAT3 75 
MAX 158 
PAX5 481 
 
Table 4.3B. Number of TFBS (Transcription factor binding sites) of 9 transcription factors 
among highly up and down regulated genes in the dataset. Transcription factors are selected from 
32 transcription factors based on CONFAC output. 
 
Notice in Table 4.3B that ETS1, ETS2, GATA2 has very high number of binding sites among 
the genes which indicate that they may play roles not only in T cell development but also in its 
neoplastic transformation.  
 
4.5 Targets of MicroRNAs Differentially Expressed between T-ALL and 
Normal Thymocytes 
 
By applying the procedure described in section 3.5, 7430 unique microRNA-gene target pairs 
(4185 genes) were obtained which also contained 143 experimentally validated microRNA-
gene target pairs. Targets of hsa-miR-150 were also included as described in the methods 
section.  
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4.6 Integration of genes and microRNAs differentially expressed in T-ALL 
and Normal Thymocytes 
 
4185 unique genes which were found to be targets of differentially regulated microRNAs were 
intersected with 6445 differentially regulated genes (>5 or < -5 fold) between T-ALL and 
Normal thymocytes. This intersection produced a list of 1561 genes.  
Among these genes, both differentially regulated and targets of differentially regulated 
microRNAs, those with at least 10 binding sites for the 9 considered transcription factors (see 
Appendix 3) were selected. A list of 64 unique genes (216 unique gene-microRNA pairs) was 
obtained. Among 216 microRNA-gene pairs, 94 microRNA-gene pairs (61 unique genes) 
were present whose expression were anti-correlated (see Appendix 4).  
A gene-microRNA network was created with these 94 microRNA-gene pairs, together with the 
transcription factors (Figure 4.3). In the constructed network, 67 out of 94 microRNA-gene 
pairs have down regulated genes in T-ALL compared to normal thymocytes, indicating that up 
regulated microRNAs may have significant role to play in T cell leukemogenesis. Down-
regulation of these genes may also be mediated by transcription factors which may act co-
operatively with the up regulated microRNAs to down regulate these genes. Some interesting 
loops, one with microRNA 22 and another with microRNA-206, were in the network. 
MicroRNA-22 targets both CEBPD and ETS2. ETS2 has binding sites in CEBPD. Similarly, 
microRNA-206 targets ETS1 and TAL1. TAL1 has binding sites for ETS2. These loops may 
have biological significance in the leukemogenesis process. Additionally, the CONFAC output 
(Appendix 3) revealed a group of genes which have all the 9 selected transcription factors 
binding sites on them (Table 4.4). In this group, there are few interesting genes (marked in 
bold in Table 4.4) which are also regulated by the microRNAs (see Table 4.5).  
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Figure 4.3. MicroRNA-Gene-Transcription factor Network in T-ALL. Triangles are transcription 
factors. Diamonds are microRNAs and round balls are genes. Red = Up regulated in T-ALL, Green = 
Down Regulated, Pink = hsa-mir-150 whose role is experimentally validated in Normal T cell 
Development. T-ALL compared to Normal thymocytes. In bold loop in the network. 
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Genes NFE2 MAX GATA2 STAT3 ATF3 TAL1 ETS2 ETS1 PAX5 
BCL11A 13 5 18 3 6 15 28 61 20 
BTBD5 5 5 23 1 5 16 23 43 11 
NTNG2 4 3 22 3 3 13 22 35 7 
LRRN3 13 1 19 2 7 8 23 33 2 
ARNTL 4 1 26 1 4 16 19 28 4 
IKZF1 9 2 11 1 2 10 24 36 6 
IRS1 1 5 13 2 6 16 18 31 6 
BMPR2 7 3 29 2 6 5 15 19 3 
NFIL3 5 3 21 2 8 5 14 23 5 
TNRC6B 9 4 5 1 4 8 16 26 6 
ZNF148 3 1 14 1 1 8 13 24 7 
ADD3 3 1 15 1 1 7 16 20 6 
NIPBL 4 2 9 2 2 4 18 23 4 
THRAP3 3 2 1 2 1 4 1 3 4 
EDEM3 1 1 1 1 1 1 5 8 1 
 
Table 4.4. Genes which have binding sites for all the 9 Transcription factors considered. 
Numbers indicate binding sites for the Transcription Factors.     
 
Genes MicroRNA MicroRNA Sign Gene Sign Relationship 
BCL11A hsa-mir-107 POSITIVE NEGATIVE anti-correlated 
LRRN3 hsa-mir-107 POSITIVE NEGATIVE anti-correlated 
IRS1 hsa-mir-126 POSITIVE NEGATIVE anti-correlated 
BMPR2 hsa-mir-145 POSITIVE NEGATIVE anti-correlated 
BCL11A hsa-mir-190 POSITIVE NEGATIVE anti-correlated 
LRRN3 hsa-mir-190 POSITIVE NEGATIVE anti-correlated 
BCL11A hsa-mir-27a POSITIVE NEGATIVE anti-correlated 
IKZF1 hsa-mir-27a POSITIVE NEGATIVE anti-correlated 
IRS1 hsa-mir-27a POSITIVE NEGATIVE anti-correlated 
ZNF148 hsa-mir-27a POSITIVE NEGATIVE anti-correlated 
ADD3 hsa-mir-27a POSITIVE NEGATIVE anti-correlated 
ARNTL hsa-mir-27a POSITIVE NEGATIVE anti-correlated 
IRS1 hsa-mir-145 POSITIVE NEGATIVE anti-correlated 
ZNF148 hsa-mir-150 UNKNOWN NEGATIVE anti-correlated 
 
Table 4.5. Targets of 9 Transcription factors regulated by microRNAs. Positive = Upregulation in 
T-ALL, Negative = Downregulation in T-ALL.         
 
 
 
54 
 
4.7 Additional Analysis on pathways 
 
All the core enrichment genes (137 in number) related to different KEGG categories were 
collected (Appendix 2) and intersected with 4185 genes (7430 microRNA-gene pairs) to 
obtain 107 microRNA-gene pairs. Among these 107 microRNA gene pairs, 42 microRNA-
gene pairs expression were found to be anti-correlated. (see Appendix 5). These 42 
microRNA-gene pairs were used to construct a microRNA target enriched KEGG genes 
network. 
Interestingly, two pathways, WNT Signaling Pathway and T cell Receptor Signaling pathway, 
were highly enriched with several upregulated microRNA targets. (Figure 4.6 and Table 4.7).  
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Figure 4.6. MicroRNA targeted GSEA core gene enriched network in T-ALL. In this network 
genes which are down regulated (colored green) are ball shaped, KEGG categories are red triangle, 
up regulated microRNAs in T-ALL are colored orange. Arrows indicate regulation. 
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GENES MicroRNAs Pathways 
CNOT6L hsa-mir-107 RNADegradation 
PPP2R5C hsa-mir-107 WNTSignalingPathway 
AXIN2 hsa-mir-107 WNTSignalingPathway 
LRP6 hsa-mir-107 WNTSignalingPathway 
CD28 hsa-mir-107 TcellReceptorSignalingpathway 
NFATC3 hsa-mir-107 TcellReceptor/WNTSignalingpathway 
AKT3 hsa-mir-107 TcellReceptorSignalingpathway 
LRP6 hsa-mir-126 WNTSignalingPathway 
CNOT6L hsa-mir-145 RNADegradation 
CD28 hsa-mir-145 TcellReceptorSignalingpathway 
SMAD4 hsa-mir-145 CellCycle 
XRN1 hsa-mir-145 RNADegradation 
SMAD4 hsa-mir-190 CellCycle 
PAPOLG hsa-mir-190 RNADegradation 
PRKACB hsa-mir-223 WNTSignalingPathway 
IL6ST hsa-mir-223 JAK-STATSignalingPathway 
DCP2 hsa-mir-27a RNADegradation 
LRP6 hsa-mir-27a WNTSignalingPathway 
CNOT1 hsa-mir-27a RNADegradation 
ICOS hsa-mir-27a TcellReceptorSignalingpathway 
PDK1 hsa-mir-27a TcellReceptorSignalingpathway 
CD28 hsa-mir-27a TcellReceptorSignalingpathway 
STAG1 hsa-mir-27a CellCycle 
YWHAB hsa-mir-27a CellCycle 
FYN hsa-mir-27a TcellReceptorSignalingpathway 
STAT1 hsa-mir-145 JAK-STATSignalingPathway 
AKT3 hsa-mir-150 TcellReceptor/WNTSignalingpathway 
CNOT6L hsa-mir-320a RNADegradation 
TBL1XR1 hsa-mir-320a WNTSignalingPathway 
SPRED2 hsa-mir-320a JAK-STATSignalingPathway 
LRP6 hsa-mir-320a WNTSignalingPathway 
CNOT4 hsa-mir-320a RNADegradation 
STAG2 hsa-mir-320a CellCycle 
 
Table 4.7. Selected Pathways/categories which have at least 3 microRNAs targeting the genes 
of the pathways/ category. Down regulated genes are colored green, up regulated microRNAs are 
colored red. Each pathway is colored with different colors. 
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5. DISCUSSION 
In the first part of the work, miR expression in human T-cell populations from sequential 
stages of maturation was profiled using microarrays. All the results presented were published 
in [77]. This is the first comprehensive analysis of miR regulation performed in human 
thymocytes as all previous studies were conducted either in mouse models or in peripheral T 
lymphocytes at later stages of development. Results indicate that each human thymocyte 
subpopulation (DP, SP CD4+, SP CD8+) is characterized by a distinct miR expression profile, 
with the pattern of miR expression reflecting the developmental relationship between 
maturation stages (Figure 4.1). A general trend was detected in up-regulated miR expression 
in the maturation from the DP to SP stage of thymocyte development. This result is consistent 
with previous studies that correlated miR levels to cell differentiation  [55] and suggests that 
miR up-regulation in this context could be important for down-regulating genes associated 
with an immature phenotype. Moreover, because immature thymocytes at the DP stage are 
subjected to both positive and negative selection through T-cell receptor-activated 
apoptotic/survival signals, the up-regulation of miRs during the maturation to SP cells could 
also play a role in suppressing genes involved in this selection process [78].  
Interestingly, some of the microRNAs which have been reported to play an important role in 
the differentiation of the lymphoid (miR-150, miR-155, miR-23a) or myeloid (miR-146, miR-
223) hematopoietic lineages  [42, 79, 80] and in the regulation of cellular proliferation or 
apoptosis (miR-150, miR-23a, miR-27a, miR-24) were up regulated in single positive stage of 
thymocyte development [81, 82]. Among these microRNAs, hsa-miR-150 was experimentally 
validated as regulator of NOTCH3, a down regulated gene in SP compared to DP. 
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In the second part of the work, gene expression profile of normal thymocytes was compared 
with that of T cell acute lymphoblastic leukemia. Differentially regulated microRNAs between 
normal thymocytes and T cell acute lymphoblastic samples were collected from scientific 
literature and combined with gene expression data to construct a network. 
For many years the main interest of the researchers was focused on discovering gene 
signatures specific to a particular T-ALL subtype based on a specific fusion gene product  [83-
85]. Indeed, different subtypes of T-ALL are associated with chromosomal translocations 
between gene codifying T cell receptors and oncogenic transcription factors forming fusion 
gene products. The meta-analysis showed several up regulated transcription factors in T-ALL 
compared to normal thymocytes independently of T-ALL subtype (Table 4.3A). Most of the up 
regulated transcription factors are not fusion gene products in T-ALL but are involved in early 
stages of T cell development in the thymus. Interestingly, a recent paper by Saida Dadi et.al  
[86] reports the interaction of TLX1 (fusion product oncogenic transcription factor in T-ALL) 
and ETS1 (Transcription Factor involved in early stages of T cell development in thymus) as a 
mechanism causing T cell maturation arrest and leukemogenesis in T-ALL. The results 
showed in Table 4.3A clearly present a group of transcription factors which may play role in 
leukemogenesis irrespectively of the T-ALL subtype.  
A TF-gene-microRNA network was then constructed, involving 9 TFs that were targeting 
strongly differentially expressed genes (Figure 4.3). In the network , there are seven up 
regulated microRNAs,  
which are found to target down regulated genes, and among them microRNA 223 was known 
to be upregulated in T-ALL  [60, 61]. MicroRNA-27 is implicated in myeloid cell differentiation l  
[87] and is highly upregulated in SP thymocytes (Figure 4.2).  
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Among the down regulated microRNAs in the network, hsa-miR-22, hsa-miR-26a, hsa-miR-
132 may be interesting candidate microRNAs for further functional studies on T-ALL as they 
are also down regulated in immature normal T cell phenotype (DP) compared to SP 
thymocyte populations.  
T cell Acute lymphoblastic leukemia arise mainly from normal T cells corresponding to either 
double negative (LYL1+), early cortical (HOX11) or late cortical (TAL1) stages of T cell 
development  [83]. This suggests that T-ALL can develop from immature T cell phenotype. 
Interstingly, ETS2, a transcription factor which we found to be up regulated in the T-ALL, was 
also up regulated in very early stages of thymocyte development. Moreover, a microRNA 
down regulated both in T- ALL and DP thymocytes, hsa-miR-22 was predicted to regulate this 
transcription factor. It is known that hsa-miR-22 is a tumour suppresor and is down regulated 
in different types of cancer  [88, 89, 90].  It thus may be interesting to clarify the functional role 
of hsa-miR-22 in T-ALL. 
Further improvement of the meta analysis will be performed and will become the starting point 
of future biological validation. 
 
 
 
  
 
 
60 
 
 
  
 
 
61 
 
APPENDIX 1 
Selection of interesting transcription factors and their target genes from 
literature 
 
Several authors for the last 10 years have extensively used high throughput genomic 
technologies to understand the oncogenic transcription factor direct gene targets or specific 
genes related to different transcription factors in T- ALL. In this work, "transcription factor 
associated genes " were collected from the literature (7 published articles) in the following 
manner.  
1) 27 human T-ALL samples expressing either high levels of HOX11 or TAL1 or LYL1 were 
used for microarray analysis by Ferrando et.al [83]. In the main article, they have highlighted 
several "top genes among 200 nearest neighbours for each transcription factor oncogenes". 
These transcription factor specific genes were collected for the meta analysis.  
2) PER-117 T-ALL cell line was used by Katrin Hoffmann et.al  [91] to stably transfect HOX11 
transcription factor. Subsequently microarray analysis was performed to identify differentially 
regulated genes as a result of HOX11 over expression. All the genes reported to be 
differentially regulated in the main paper were assembled for meta analysis.  
3) Teresa Palomero et.al [92] identified 71 genes whose promoters may be occupied by 
oncogenic transcription factor TAL1 by ChIP on chip experiments in Jurkat cells. They further 
categorised these 71 genes into different functional categories. All the genes were collected 
except those belonging to " Unknown Class" for the purpose of robust meta analysis. 
4) In the year 2007, Emmanuelle Clappier et.al  [85]reported a gene cluster specific to TCRB-
MYB translocation in very young children. In the microarray analysis this cluster was identified 
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specific for 4 TCRB-MYB translocation patients. This reported gene cluster was also included 
in the analysis. 
5) Kim de Keersmaecker et.al in the year 2010 [84], performed an interesting analysis with T 
cell acute lymphoblastic leukemia human samples. They at first discovered a mouse T-ALL 
gene signature then performed a GSEA analysis with this signature on human T-ALL 
samples. All the "leading edge genes" were collected from the supplementary data of the 
paper.  
6) Adam. A. Margolin et.al  [93] in the year 2009 reported in their paper a list of validated 
genes (by ChIP or qPCR) which are targets of NOTCH1, HES and MYC transcription factors. 
The gene set reported by them is included in the meta analysis list.  
7) Finally a list of "high confidence" targets of TAL1 (some of them are also targets of 
cofactors HEB, RUNX1,GATA3 and E2A transcription factors) are collected from the recently 
published paper of Takaomi Sanda [94] and included in the list for the purpose of meta 
analysis. 
After the collection of data, it was necessary to look for 1) If any gene is reported in multiple 
papers or 2) If a gene is regulated by multiple transcription factors or is specific to 
upregulation of multiple transcription factors. For this purpose a matrix is constructed. If a 
gene is reported in a publication gets a score 1. Addition of the scores for each gene across 7 
publications, gives the total score of a gene. The genes with high scores (> 1) are important 
as they are occurring multiple times in the collected data and may have very significant role to 
play in T cell oncogenesis.  
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Out of 635 genes collected from the seven chosen papers, 19 genes were found to be 
reported in more than one paper (see Table A1.1). RUNX1 tops the list - mentioned in three 
key papers. Remaining genes are reported in two articles. RUNX1 was described to be a 
TAL1 specific gene [83]. It was also one of the genes which was present in the human TLX 
transcription factor signature [84].  
Finally RUNX1 promoter was also reported to be bound by TAL1, HEB, E2A, GATA3 
transcription factors [94]. Another gene which was found to be regulated by all these 
transcription factors was SELL which was also described to be a LYL1 specific gene [83]. 
CCNA2 and TOP2A are HOX11 transcription factor (TLX1) [83] specific genes and also found 
to be up regulated in patients having TCRB-MYB translocation. ITGAL is a gene found to be 
specific for both TLX transcription factor  [84] as well as TAL1 transcription factor [83]. 
BCL2, an anti apoptotic gene in lymphocytes, was shown to be specific for LYL1 transcription 
factor and was also found to be up regulated with the enforced over expression of 
HOX11(TLX1) [91]. Histone cluster HIST1H2K is also another gene which is highly expressed 
with the overexpression of HOX11 and was found to be an experimentally validated target of 
MYC [93].NR4A3 is another gene upregulated with the overexpression of HOX11 and is also 
a direct target of TAL1 (ChIP on chip) [25]. TCF7 is specific for TLX1 and regulated by TAL1 
where as KIF11 is up regulated in TCRB-MYB translocation patients and is a human TLX 
transcription factor specific gene. TOX, ADAM10, TSPAN2, STAT5A,STAT5B, 
RASGRP1,KIF5B, REEP5 are the genes bounded by TAL1 and its cofactors and are also 
human TLX transcription factors specific.  
Therefore in conclusion there are a set of genes in T-ALL patients which are under the control 
of several transcription factors (whose roles are well studied in T-ALL). Expression levels of 
these genes are probably dependent on the combined effect of activating or repressing 
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function of these transcription factors. These genes are important to be considered as 
potential targets of therapy as they are target genes of more than one transcription factor 
implicated in T- ALL. 
 
Table A1.1. Genes which are reported to be specific for more than one transcription factor 
among 7 collected T-ALL related articles.  
 
Gene Adolfo 
Ferrando  
(2002) 
Katrin 
Hoffmann  
(2004) 
Teresa 
Palomero  
(2006) 
Emmanuelle 
Clappier  
(2007) 
Kim De 
Keersmaecker 
(2010) 
Adam 
Margolin 
(2009) 
Takaomi 
Sanda  
(2012) 
Score 
RUNX1 1 0 0 0 1 0 1 3 
CCNA2 1 0 0 1 0 0 0 2 
TOP2A 1 0 0 1 0 0 0 2 
TAL1 1 0 0 0 0 0 1 2 
ITGAL 1 0 0 0 1 0 0 2 
SELL 1 0 0 0 0 0 1 2 
BCL2 1 1 0 0 0 0 0 2 
HIST1H2K 0 1 0 0 0 1 0 2 
NR4A3 0 1 1 0 0 0 0 2 
TCF7 0 0 1 0 1 0 0 2 
KIF11 0 0 0 1 1 0 0 2 
TOX 0 0 0 0 1 0 1 2 
ADAM10 0 0 0 0 1 0 1 2 
TSPAN2 0 0 0 0 1 0 1 2 
KIF5B 0 0 0 0 1 1 0 2 
STAT5B 0 0 0 0 1 0 1 2 
RASGRP1 0 0 0 0 1 0 1 2 
REEP5 0 0 0 0 1 0 1 2 
STAT5A 0 0 0 0 1 0 1 2 
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APPENDIX 2 
Gene Set Enrichment Analysis (GSEA) 
 
GSEA software (in the GseaPreranked  version) was used together with Kegg database 
(ftp.broadinstitute.org://pub/gsea/gene_sets/c2.cp.kegg.v3.1.symbols.gmt). Ranked file used 
in the analysis was the list of differentially regulated genes arranged in the descending order 
of fold change. Gene set enrichment analysis is based on an "enrichment score" which 
indicates to what degree a particular pathway (gene set) is over representated at the top or 
the bottom of the ranked list. Enriched Pathways which have "q- FDR value < 0.1" are 
reported.  
Gene Set Enrichment Analysis identified 14 gene set categories (which have FDR value less 
than 0.1) likely to be involved in T cell acute lymphoblastic leukemia. These are KEGG_ 
Haematopoetic Cell lineage (35 genes), KEGG_ T cell Receptor Signaling pathway (55 
genes), KEGG _Primary Immunodeficiency (15 genes), KEGG_Cell Adhesion Molecules (46 
genes), KEGG_ Antigen Processing and Antigen (23 genes), KEGG_ ABC Transporters (16 
genes), KEGG_RNA Degradation (29 genes), KEGG_ Arachidonic Acid Metabolism (18 
genes), KEGG_JAK STAT signaling pathway (51 genes), KEGG_ Endrometrial Cancer (23 
genes), KEGG_Phosphatidylinositol Signaling (34 genes), KEGG_Basal Cell Carcinoma (23 
genes), KEGG_Cell Cycle (50 genes), KEGG_WNT Signaling pathway (66 genes). 
Enrichment plots for the KEGG gene sets are composed of core enrichment genes which are 
mainly present at the bottom of the ranking list (negative -correlation) indicating a trend in 
down regulation of several key genes in T-ALL as compared to normal thymocytes.  
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Figure A2.1 Gene Set Enrichment plots for the 14 identified gene set categories. 
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Figure A2.1 Gene Set Enrichment plots for the 14 identified gene set categories. 
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APPENDIX 3 
Confac software was used to obtain the following table. For each differentially expressed 
gene is reported the number of predicted transcription factor binding sites (for each of the 9 
considered transcription factors). 
 
Genes NFE2 MAX GATA2 STAT3 ATF3 TAL1 ETS2 ETS1 PAX5 sum 
BCL11A 13 5 18 3 6 15 28 61 20 169 
SMPD3 9 1 20 0 7 17 28 57 18 157 
DACH1 9 2 39 0 6 14 25 41 7 143 
BTBD5 5 5 23 1 5 16 23 43 11 132 
HIVEP2 6 2 26 0 8 13 23 44 8 130 
MTSS1 5 0 16 2 8 14 28 45 7 125 
NTNG2 4 3 22 3 3 13 22 35 7 112 
LRRN3 13 1 19 2 7 8 23 33 2 108 
DAAM1 8 2 27 0 2 17 13 28 8 105 
ARNTL 4 1 26 1 4 16 19 28 4 103 
ELK3 8 0 12 3 6 8 22 37 6 102 
IKZF1 9 2 11 1 2 10 24 36 6 101 
IRS1 1 5 13 2 6 16 18 31 6 98 
SKAP1 5 0 21 0 4 4 26 33 3 96 
EGR3 5 6 5 0 2 13 13 31 15 90 
BMPR2 7 3 29 2 6 5 15 19 3 89 
NFIL3 5 3 21 2 8 5 14 23 5 86 
DFNB31 6 1 11 0 3 12 18 29 5 85 
TSPAN7 7 0 19 0 5 6 17 22 8 84 
PTEN 8 6 18 0 5 10 12 17 3 79 
TNRC6B 9 4 5 1 4 8 16 26 6 79 
ZNF148 3 1 14 1 1 8 13 24 7 72 
MARCKS 3 4 12 0 2 14 10 16 9 70 
ADD3 3 1 15 1 1 7 16 20 6 70 
FCER1G 6 0 5 1 1 11 16 21 8 69 
NIPBL 4 2 9 2 2 4 18 23 4 68 
EIF4A1 4 2 3 0 4 9 11 21 10 64 
CAMK1D 3 4 9 0 2 9 11 20 6 64 
CD247 6 0 13 0 1 8 12 19 4 63 
TCF8 4 0 10 1 5 6 14 17 3 60 
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HS3ST3B1 2 2 11 0 1 8 11 21 2 58 
ACPL2 6 1 11 0 3 6 7 16 5 55 
STRN 4 0 12 0 3 3 12 19 0 53 
IGFBP7 3 0 12 2 4 4 10 12 6 53 
DGKA 4 0 3 3 1 7 13 16 3 50 
RAG1 1 0 15 0 2 6 7 14 4 49 
SCRN1 4 2 12 0 1 3 10 14 2 48 
HIPK1 2 2 14 0 3 6 9 11 1 48 
ABCA1 5 3 4 0 1 9 7 14 3 46 
AXIN2 1 0 10 0 0 10 7 12 6 46 
IGF2BP3 0 6 3 0 0 7 9 17 3 45 
CALM3 5 0 10 0 0 8 3 11 8 45 
IL23A 0 0 3 0 5 9 11 13 3 44 
SP1 2 1 3 0 1 3 10 19 5 44 
HHEX 3 0 5 0 1 4 13 15 2 43 
RASSF3 3 0 8 1 1 6 11 12 1 43 
MAN2A1 4 0 14 1 2 2 8 11 1 43 
ZNF638 3 0 8 0 4 2 7 16 1 41 
IRX5 3 1 2 0 2 7 6 15 5 41 
KIAA1212 1 1 4 0 3 5 12 13 2 41 
SRPK2 3 1 16 0 3 2 6 8 0 39 
ID3 2 0 3 0 4 4 10 14 2 39 
WASL 3 0 8 1 4 7 4 7 5 39 
CKAP4 3 0 1 0 0 5 12 15 3 39 
ABCD3 5 0 12 0 0 1 8 12 1 39 
ITGAV 5 0 11 0 0 1 9 11 2 39 
RECK 1 1 11 0 1 4 8 11 1 38 
NFE2 0 0 8 0 3 3 6 16 2 38 
CDK6 2 2 3 0 3 4 8 11 4 37 
CALN1 3 1 11 0 0 5 6 7 4 37 
NPEPPS 2 0 11 0 3 7 3 7 4 37 
BCL2L1 2 2 1 0 2 4 7 11 7 36 
TUBD1 0 0 2 0 0 6 7 14 6 35 
BTBD11 3 0 6 0 0 5 6 11 3 34 
WNK1 4 0 0 0 0 7 7 13 3 34 
MAFF 2 3 0 0 2 5 9 11 1 33 
PTPRM 6 0 7 1 2 4 4 7 1 32 
LYN 3 0 6 1 2 2 8 9 1 32 
TAL1 1 0 6 0 0 8 4 9 4 32 
S100A4 1 0 0 3 0 7 5 10 6 32 
GSPT1 0 2 4 2 0 5 5 8 4 30 
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ACTR2 3 0 8 0 1 4 5 7 1 29 
BHLHB2 3 4 0 0 3 1 3 7 7 28 
ITPR2 0 0 11 0 2 0 5 9 1 28 
NMT2 4 0 13 0 0 3 2 3 2 27 
DDX6 0 0 8 0 0 2 5 12 0 27 
FLJ22531 2 0 3 0 0 4 6 11 1 27 
C15orf29 0 0 7 1 1 2 6 9 0 26 
RAG2 5 0 6 0 2 1 5 7 0 26 
EWSR1 3 2 2 0 2 4 4 7 2 26 
RUFY3 1 0 6 0 0 3 7 8 1 26 
ATF7IP 3 2 6 0 0 3 4 6 1 25 
FNIP1 0 2 6 0 0 2 6 9 0 25 
JUN 0 0 2 0 2 4 4 7 5 24 
ADAM10 2 0 5 0 3 3 5 6 0 24 
SLAMF1 3 0 2 2 0 1 6 8 1 23 
ALAS2 2 1 6 2 0 1 4 6 1 23 
JAK1 1 0 5 0 3 4 3 7 0 23 
AQP3 2 0 3 0 0 2 7 8 1 23 
PCAF 1 1 0 1 0 3 7 10 0 23 
KRIT1 1 0 0 1 0 3 5 9 4 23 
TAF15 2 1 2 0 4 3 2 5 3 22 
FBLN5 3 0 1 1 2 2 6 6 1 22 
ASXL2 1 2 4 0 1 5 1 3 4 21 
CBFA2T2 1 0 3 0 2 3 3 6 3 21 
TPM4 1 0 1 0 4 3 4 8 0 21 
THRAP3 3 2 1 2 1 4 1 3 4 21 
PLXDC1 3 2 1 0 2 2 3 6 1 20 
CTHRC1 2 3 0 0 0 3 3 6 3 20 
RASSF6 2 0 2 2 0 1 6 6 1 20 
SLC35A3 0 0 7 0 0 2 4 7 0 20 
S100A9 1 0 1 0 0 2 4 10 2 20 
EDEM3 1 1 1 1 1 1 5 8 1 20 
COG3 2 2 4 0 1 5 3 3 0 20 
SPEN 2 0 5 1 0 2 2 8 0 20 
MTA3 1 0 3 0 1 3 4 6 1 19 
EXOC5 1 0 0 1 0 2 5 8 2 19 
LRRC16 3 0 4 0 0 4 1 4 3 19 
ELOVL4 1 1 1 0 4 1 3 4 3 18 
STK38 1 0 3 0 0 3 4 6 1 18 
CD4 3 0 4 0 0 1 5 5 0 18 
PRDM2 4 1 2 0 2 0 4 4 1 18 
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CDC27 0 0 8 0 3 4 1 1 1 18 
SLC4A1 2 0 5 0 0 2 2 3 4 18 
EGR2 2 0 2 1 2 1 4 5 1 18 
TCF7 0 0 4 0 0 2 3 5 3 17 
SOS1 1 1 3 0 1 0 3 7 1 17 
PAFAH2 0 0 7 0 0 2 3 4 1 17 
IKZF3 2 0 7 0 1 0 3 4 0 17 
ITPKB 2 0 3 0 0 3 2 6 1 17 
ALOX5 0 0 2 0 1 1 6 7 0 17 
CTLA4 1 0 3 0 0 1 5 6 0 16 
PLEK 1 0 5 0 0 1 4 4 1 16 
RASGRP1 0 0 7 0 0 3 2 3 1 16 
G0S2 3 2 3 0 2 0 2 2 1 15 
MGC29671 2 0 0 0 1 1 4 5 2 15 
RBM6 0 0 0 0 1 3 3 3 5 15 
MMP9 1 0 1 0 0 1 5 6 1 15 
HIST1H1E 0 0 5 0 2 0 1 4 2 14 
CMTM7 1 0 1 0 0 2 4 4 2 14 
DOK3 5 0 0 0 1 1 2 3 2 14 
NAPE-PLD 1 0 5 0 0 3 2 3 0 14 
CD6 2 0 0 0 1 1 4 5 1 14 
NOTCH3 1 2 0 0 0 3 2 5 1 14 
EDEM1 0 0 1 1 1 2 4 5 0 14 
PTPRC 2 0 2 1 1 0 4 4 0 14 
YME1L1 1 0 2 0 1 0 3 6 0 13 
DSG2 0 0 4 0 0 0 4 5 0 13 
ESCO1 1 1 1 0 0 2 3 4 1 13 
MAN1C1 2 0 1 0 0 5 0 2 3 13 
TSHR 3 0 4 1 0 1 1 1 2 13 
PHF3 1 0 5 0 2 0 0 4 1 13 
ITK 0 0 4 0 2 0 2 3 2 13 
RIPK4 0 0 2 0 1 3 2 2 3 13 
LATS2 0 2 1 1 2 0 3 3 0 12 
FLJ20125 0 0 2 2 0 0 3 5 0 12 
INSIG2 1 0 0 1 0 1 3 5 1 12 
PDE7A 2 0 5 0 0 1 2 2 0 12 
ITGAM 0 0 2 0 0 0 4 6 0 12 
PIK3C2A 1 0 1 1 2 1 2 3 0 11 
BCL2L11 0 1 0 0 2 3 1 2 2 11 
CLEC11A 0 0 0 1 0 0 2 6 2 11 
ANXA1 1 0 1 0 0 0 4 5 0 11 
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CFLAR 2 1 0 0 3 1 2 2 0 11 
BCL2A1 1 0 2 1 0 1 2 4 0 11 
MUC20 0 0 1 0 0 2 3 4 1 11 
IL21R 1 0 0 0 2 2 3 3 0 11 
SLC29A1 0 2 2 0 0 2 2 2 0 10 
GGA2 1 1 0 0 1 4 1 2 0 10 
VPREB1 0 0 1 0 0 2 2 4 1 10 
TYROBP 0 0 0 0 0 1 3 6 0 10 
SATB1 2 0 2 0 0 0 2 3 1 10 
KIAA0980 3 0 1 0 1 0 2 3 0 10 
IL1A 1 0 2 0 0 1 2 3 0 9 
MYO7B 0 1 2 0 0 0 3 3 0 9 
ITGA4 0 5 2 0 0 0 1 1 0 9 
AGXT2L2 1 0 1 0 0 1 0 2 3 8 
ANXA3 0 0 3 0 0 0 2 3 0 8 
STK32B 0 0 0 0 0 2 3 3 0 8 
FTH1 0 0 4 0 0 1 1 1 1 8 
BLVRB 0 0 1 0 1 0 0 2 4 8 
STOM 1 0 1 0 0 2 1 2 1 8 
TPP2 0 2 0 0 0 1 2 3 0 8 
NFKBIZ 0 0 2 0 0 0 2 3 0 7 
COCH 1 0 1 0 0 0 1 2 2 7 
LGALS1 0 0 0 1 0 4 1 1 0 7 
TIMP1 2 0 0 0 0 2 1 1 0 6 
SLC7A6 0 1 0 0 1 2 1 1 0 6 
ID1 2 0 0 0 3 1 0 0 0 6 
SUV420H1 0 0 0 0 0 3 1 2 0 6 
CSNK1A1 2 0 0 0 0 1 1 1 1 6 
TOP1 0 3 0 0 1 1 0 1 0 6 
LTF 1 0 0 0 0 2 1 2 0 6 
WSB1 1 1 0 0 0 0 1 3 0 6 
SGPP1 1 0 3 1 0 1 0 0 0 6 
PHF20L1 0 3 2 0 0 0 0 0 1 6 
BPI 0 0 0 0 0 3 1 2 0 6 
ACSBG1 0 0 0 0 0 0 2 3 0 5 
CCL5 1 1 0 0 0 0 1 2 0 5 
IL7R 1 0 0 1 0 0 1 2 0 5 
STX17 0 0 3 0 1 0 0 1 0 5 
TCF12 0 0 3 0 0 0 0 0 2 5 
SENP7 0 0 0 0 0 0 1 2 2 5 
B3GNT5 1 0 2 0 0 0 1 1 0 5 
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TMEM63A 0 0 1 0 0 1 1 1 1 5 
MPO 0 0 1 0 0 0 2 2 0 5 
SLA 0 0 2 0 0 1 1 1 0 5 
ELA2 1 0 1 0 1 1 0 0 0 4 
DNMBP 1 0 0 0 0 1 1 1 0 4 
MYO1F 0 0 0 0 0 0 2 2 0 4 
CHRNA3 0 0 0 0 0 1 1 1 1 4 
CDA 1 0 0 0 0 0 1 2 0 4 
NFATC3 0 0 0 0 0 0 2 2 0 4 
CIRBP 2 0 0 1 0 1 0 0 0 4 
CST7 1 0 1 0 0 0 1 1 0 4 
LARS 0 0 1 0 0 0 1 1 1 4 
ATM 0 0 2 0 1 0 0 0 0 3 
TMEM106B 1 0 1 0 0 0 0 1 0 3 
HERC4 0 1 1 0 0 0 0 1 0 3 
HBB 0 0 1 0 1 0 0 1 0 3 
LCN2 0 0 0 0 0 1 1 1 0 3 
NKG7 0 0 0 0 0 1 1 1 0 3 
GRAMD3 0 0 0 0 0 0 1 1 1 3 
HERC4 0 1 1 0 0 0 0 1 0 3 
MMP8 1 0 0 0 0 0 1 1 0 3 
STAT1 0 0 0 0 0 0 1 2 0 3 
PYGL 0 0 1 0 0 0 1 1 0 3 
AP3D1 1 2 0 0 0 0 0 0 0 3 
MS4A3 0 0 0 0 0 0 1 1 1 3 
PROSC 0 0 0 0 1 0 0 1 1 3 
TMEM33 1 0 1 0 1 0 0 0 0 3 
TIMP2 0 0 0 0 0 0 1 1 0 2 
ARG1 0 0 2 0 0 0 0 0 0 2 
MTMR1 0 0 1 0 0 1 0 0 0 2 
SERPINA1 0 0 0 0 0 0 1 1 0 2 
CEBPD 0 0 0 0 0 0 1 1 0 2 
FUS 0 0 0 0 0 0 0 1 1 2 
CHI3L1 1 0 0 0 0 0 0 1 0 2 
S100A8 0 0 0 0 0 2 0 0 0 2 
SF1 0 0 0 0 0 1 0 0 1 2 
MDM4 0 0 0 0 0 0 0 2 0 2 
KIAA0100 0 0 2 0 0 0 0 0 0 2 
DPP4 1 0 0 0 0 0 0 0 0 1 
LY9 0 0 0 0 0 0 0 1 0 1 
ASPM 0 0 0 0 0 1 0 0 0 1 
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TOP2A 1 0 0 0 0 0 0 0 0 1 
TRIM58 0 0 0 0 0 0 0 1 0 1 
CD8A 0 0 1 0 0 0 0 0 0 1 
C2orf43 0 0 1 0 0 0 0 0 0 1 
EPHX2 0 0 0 0 0 1 0 0 0 1 
CD8B 0 0 0 1 0 0 0 0 0 1 
TMEM168 0 0 0 0 0 1 0 0 0 1 
CTSW 0 0 0 0 0 0 0 1 0 1 
CD8A 0 0 1 0 0 0 0 0 0 1 
CPLX1 0 0 0 0 0 0 0 0 1 1 
 
Figure A3.1 List of genes differentially regulated genes (>5 or < -5 fold) between T-ALL and 
normal thymocytes with detailed number of transcription factor binding sites for each 
transcription factor.  
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APPENDIX 4 
Genes which were differentially regulated (>5 or < -5 fold) and has at least a total of 10 
binding sites for the 9 Ttranscription factors (163 genes obtained from CONFAC software, 
(APPENDIX-3) were intersected with the 4185 genes targeted by differentially expressed 
microRNAs to obtain a list of 64 unique genes (216 unique gene-microRNA pairs). Among 
216 microRNA-gene pairs, 94 microRNA- gene pairs (61 unique genes) were present whose 
expression were anti-correlated.  
GENE MicroRNA MicroRNA Sign GENE Sign RELATIONSHIP 
EXOC5 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
NMT2 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
SLC35A3 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
AXIN2 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
BCL11A hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
LRRN3 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
RBM6 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
DACH1 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
PHF20L1 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
TAF15 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
NFATC3 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
RECK hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
PROSC hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
ACSBG1 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
GRAMD3 hsa-mir-107 POSITIVE NEGATIVE ANTI- CORRELATED 
IRS1 hsa-mir-126 POSITIVE NEGATIVE ANTI- CORRELATED 
DDX6 hsa-mir-132 NEGATIVE POSITIVE ANTI- CORRELATED 
SP1 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
CAMK1D hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
ABCA1 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
DACH1 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
FUS hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
RAG1 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
C15oRf29 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
BMPR2 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
BCL11A hsa-mir-190 POSITIVE NEGATIVE ANTI- CORRELATED 
PHF20L1 hsa-mir-190 POSITIVE NEGATIVE ANTI- CORRELATED 
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LRRN3 hsa-mir-190 POSITIVE NEGATIVE ANTI- CORRELATED 
WSB1 hsa-mir-190 POSITIVE NEGATIVE ANTI- CORRELATED 
TOP1 hsa-mir-193b NEGATIVE POSITIVE ANTI- CORRELATED 
DDX6 hsa-mir-205 NEGATIVE POSITIVE ANTI- CORRELATED 
B3GNT5 hsa-mir-205 NEGATIVE POSITIVE ANTI- CORRELATED 
PLEK hsa-mir-205 NEGATIVE POSITIVE ANTI- CORRELATED 
TOP1 hsa-mir-205 NEGATIVE POSITIVE ANTI- CORRELATED 
CDK6 hsa-mir-206 NEGATIVE POSITIVE ANTI- CORRELATED 
TAL1 hsa-mir-206 NEGATIVE POSITIVE ANTI- CORRELATED 
PIK3C2A hsa-mir-223 POSITIVE NEGATIVE ANTI- CORRELATED 
SP1 hsa-mir-223 POSITIVE NEGATIVE ANTI- CORRELATED 
PHF20L1 hsa-mir-223 POSITIVE NEGATIVE ANTI- CORRELATED 
DDX6 hsa-mir-22 NEGATIVE POSITIVE ANTI- CORRELATED 
CEBPD hsa-mir-22 NEGATIVE POSITIVE ANTI- CORRELATED 
LGALS1 hsa-mir-22 NEGATIVE POSITIVE ANTI- CORRELATED 
CDK6 hsa-mir-22 NEGATIVE POSITIVE ANTI- CORRELATED 
CDK6 hsa-mir-26a NEGATIVE POSITIVE ANTI- CORRELATED 
FNIP1 hsa-mir-26a NEGATIVE POSITIVE ANTI- CORRELATED 
ESCO1 hsa-mir-26a NEGATIVE POSITIVE ANTI- CORRELATED 
TOP1 hsa-mir-26a NEGATIVE POSITIVE ANTI- CORRELATED 
BCL11A hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
SP1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
IKZF1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
SUV420H1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
IRS1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
SMPD3 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
EGR3 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
CALM3 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
ZNF148 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
SGPP1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
GSPT1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
SLC35A3 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
ID3 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
MARCKS hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
FBLN5 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
ABCA1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
WSB1 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
ADD3 hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
ARNTL hsa-mir-27a POSITIVE NEGATIVE ANTI- CORRELATED 
IRS1 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
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STAT1 hsa-mir-145 POSITIVE NEGATIVE ANTI- CORRELATED 
SP1 hsa-mir-150 Unknown NEGATIVE ANTI- CORRELATED 
ZNF148 hsa-mir-150 Unknown NEGATIVE ANTI- CORRELATED 
EGR2 hsa-mir-150 Unknown NEGATIVE ANTI- CORRELATED 
NOTCH3 hsa-mir-150 Unknown NEGATIVE ANTI- CORRELATED 
TCF12 hsa-mir-150 Unknown NEGATIVE ANTI- CORRELATED 
TAL1 hsa-mir-296-5p NEGATIVE POSITIVE ANTI- CORRELATED 
CDK6 hsa-mir-320a NEGATIVE POSITIVE ANTI- CORRELATED 
CDC27 hsa-mir-433 NEGATIVE POSITIVE ANTI- CORRELATED 
TOP1 hsa-mir-433 NEGATIVE POSITIVE ANTI- CORRELATED 
TOP1 hsa-mir-549 NEGATIVE POSITIVE ANTI- CORRELATED 
NFKBIZ hsa-mir-601 NEGATIVE POSITIVE ANTI- CORRELATED 
DDX6 hsa-mir-646 NEGATIVE POSITIVE ANTI- CORRELATED 
CDK6 hsa-mir-646 NEGATIVE POSITIVE ANTI- CORRELATED 
LATS2 hsa-mir-646 NEGATIVE POSITIVE ANTI- CORRELATED 
CDC27 hsa-mir-646 NEGATIVE POSITIVE ANTI- CORRELATED 
DDX6 hsa-mir-650 NEGATIVE POSITIVE ANTI- CORRELATED 
PRDM2 hsa-mir-708 NEGATIVE POSITIVE ANTI- CORRELATED 
 
Table A4.1 Anti-correlated genes and microRNAs: 94 gene-microRNA pairs, 61 genes. 
POSITIVE=Upregulated in T-ALL, NEGATIVE = Down Regulated in T-ALL. 
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APPENDIX 5 
All the core enrichment genes (137 in number) related to different KEGG categories were 
collected (Appendix- 2) and intersected with 4185 genes (7430 microRNA-gene pairs) to 
obtain 107 microRNA-gene pairs. Among these 107 microRNA gene pairs, 42 microRNA-
gene pairs expression were found to be anti-correlated. 
 
GENE MicroRNA 
CNOT6L hsa-mir-107 
PPP2R5C hsa-mir-107 
AXIN2 hsa-mir-107 
LRP6 hsa-mir-107 
CD28 hsa-mir-107 
NFATC3 hsa-mir-107 
AKT3 hsa-mir-107 
LRP6 hsa-mir-126 
CNOT6L hsa-mir-145 
ABCA1 hsa-mir-145 
CD28 hsa-mir-145 
SMAD4 hsa-mir-145 
RAG1 hsa-mir-145 
XRN1 hsa-mir-145 
NLGN4X hsa-mir-190 
SMAD4 hsa-mir-190 
PAPOLG hsa-mir-190 
PRKACB hsa-mir-223 
PIK3C2A hsa-mir-223 
IL6ST hsa-mir-223 
DCP2 hsa-mir-27a 
LRP6 hsa-mir-27a 
NLGN4X hsa-mir-27a 
CALM3 hsa-mir-27a 
CNOT1 hsa-mir-27a 
ICOS hsa-mir-27a 
PDK1 hsa-mir-27a 
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CD28 hsa-mir-27a 
STAG1 hsa-mir-27a 
YWHAB hsa-mir-27a 
ABCA1 hsa-mir-27a 
CREB1 hsa-mir-27a 
FYN hsa-mir-27a 
STAT1 hsa-mir-145 
AKT3 hsa-mir-150 
CNOT6L hsa-mir-320a 
TBL1XR1 hsa-mir-320a 
CALM3 hsa-mir-320a 
SPRED2 hsa-mir-320a 
LRP6 hsa-mir-320a 
CNOT4 hsa-mir-320a 
STAG2 hsa-mir-320a 
 
Table A5.1 List of 42 core enriched anti-correlated gene-microRNA pairs. 
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